<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biosci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Biosci. Rep</journal-id><journal-id journal-id-type="hwp">ppbioscirep</journal-id><journal-id journal-id-type="publisher-id">BSR</journal-id><journal-title-group><journal-title>Bioscience Reports</journal-title></journal-title-group><issn pub-type="ppub">0144-8463</issn><issn pub-type="epub">1573-4935</issn><publisher><publisher-name>Portland Press Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6328934</article-id><article-id pub-id-type="doi">10.1042/BSR20171505</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Articles</subject></subj-group><subj-group subj-group-type="overline"><subject>Review Article</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>34</subject><subject>37</subject><subject>45</subject><subject>2</subject></subj-group></article-categories><title-group><article-title>Influenza virus N-linked glycosylation and innate immunity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>York</surname><given-names>Ian&#x000a0;A.</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Stevens</surname><given-names>James</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9090-995X</contrib-id><name><surname>Alymova</surname><given-names>Irina&#x000a0;V.</given-names></name><xref ref-type="aff" rid="A1"/><xref ref-type="corresp" rid="COR1"/></contrib><aff id="A1">Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 30329, U.S.A.</aff></contrib-group><author-notes><corresp id="COR1"><bold>Correspondence:</bold> Irina V. Alymova (<email>ialymova@cdc.gov</email>)</corresp></author-notes><pub-date pub-type="epreprint"><day>14</day><month>12</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>08</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><day>31</day><month>1</month><year>2019</year></pub-date><volume>39</volume><issue>1</issue><elocation-id>BSR20171505</elocation-id><history><date date-type="received"><day>15</day><month>10</month><year>2018</year></date><date date-type="rev-recd"><day>03</day><month>12</month><year>2018</year></date><date date-type="accepted"><day>13</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 The Author(s).</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CC BY)</ext-link>.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="bsr-39-bsr20171505.pdf"/><abstract><p>Influenza viruses cause seasonal epidemics and sporadic pandemics in humans. The virus&#x02019;s ability to change its antigenic nature through mutation and recombination, and the difficulty in developing highly effective universal vaccines against it, make it a serious global public health challenge. Influenza virus&#x02019;s surface glycoproteins, hemagglutinin and neuraminidase, are all modified by the host cell&#x02019;s N-linked glycosylation pathways. Host innate immune responses are the first line of defense against infection, and glycosylation of these major antigens plays an important role in the generation of host innate responses toward the virus. Here, we review the principal findings in the analytical techniques used to study influenza N-linked glycosylation, the evolutionary dynamics of N-linked glycosylation in seasonal versus pandemic and zoonotic strains, its role in host innate immune responses, and the prospects for lectin-based therapies. As the efficiency of innate immune responses is a critical determinant of disease severity and adaptive immunity, the study of influenza glycobiology is of clinical as well as research interest.</p></abstract><kwd-group><kwd>influenza</kwd><kwd>innate</kwd><kwd>immunity</kwd></kwd-group><counts><page-count count="15"/></counts></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>Influenza viruses have caused epidemic and pandemic disease in humans for hundreds of years [<xref rid="B1" ref-type="bibr">1</xref>], but the disease remains difficult to predict and prevent. Three types of influenza viruses infect humans: A, B, and C. While wild waterfowl and other birds are the primary reservoirs of influenza A virus (IAV) [<xref rid="B2" ref-type="bibr">2</xref>], humans are the primary host and reservoir of influenza B and C viruses (IBV and ICV, respectively) [<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>]. In addition to the primary reservoirs, IAV can infect many other species, including domestic species such as pigs, horses, dogs, and cats [<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B5" ref-type="bibr">5</xref>]. IBV and ICV are less broadly infectious but have been shown to infect seals [<xref rid="B6" ref-type="bibr">6</xref>], pigs, and dogs [<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>]. There are therefore many sources of influenza virus exposed to humans.</p><p>Among the three influenza types, IAV is the greatest public health concern because of its ability to cause not only widespread seasonal epidemics, but also pandemics originating from zoonotic infections [<xref rid="B9" ref-type="bibr">9&#x02013;13</xref>]. IBV has not yet been associated with pandemics but causes seasonal epidemics and is responsible for &#x0223c;25% of human seasonal influenza infections [<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>]. Together, seasonal epidemics of IAV and IBV can cause up to 5 million infections and 500,000 deaths annually [<xref rid="B16" ref-type="bibr">16</xref>]. Type C virus typically causes a mild respiratory illness [<xref rid="B17" ref-type="bibr">17</xref>] and in contrast with IAV and IBV, it is not included in the composition of seasonal influenza vaccines. As it is of less public health concern, ICV has been less studied than IAV and IBV. Therefore, this review will focus on IAV and IBV only.</p></sec><sec id="sec2"><title>Influenza glycoproteins</title><p>Influenza viruses belong to the Orthomyxoviridae family and contain a genome consisting of eight negative sense RNA segments. Segments four and six encode two major virus surface glycoproteins, the hemagglutinin (HA), a trimeric lectin, and the neuraminidase (NA), a tetrameric enzyme (<xref ref-type="fig" rid="F1">Figure 1</xref>A). The number of NAs on the viral surface is up to 10-fold less than HAs [<xref rid="B18" ref-type="bibr">18</xref>]. The external parts of both proteins consist of a stalk and globular head regions. HA is the virus&#x02019;s primary receptor-binding protein, binding to specific receptors that possess terminal <italic>N-</italic>acetylneuraminic acid (Neu5Ac or sialic acid [SA]), particularly on epithelial cells and mucins of human respiratory tracts (RT) [<xref rid="B19" ref-type="bibr">19</xref>]. SA-independent binding and internalization of influenza virus HA also occur via specific cell-surface proteins on alveolar and recruited monocytes/macrophages, dendritic cells (DCs), and B cells [<xref rid="B20" ref-type="bibr">20&#x02013;26</xref>]. Binding to cell receptors is the first step in the process leading to a productive virus infection. As with HA, NA also has specificity for terminal SA [<xref rid="B27" ref-type="bibr">27</xref>]. The primary role of influenza virus NA is to cleave SA residues from virus and cellular glycoproteins at the time of the budding of newly formed virions from the surface to prevent virus-self aggregation and enable its release from infected cells. As well, NA cleaves SA from the mucins of the RT to facilitate viral movement to target cells [<xref rid="B28" ref-type="bibr">28&#x02013;30</xref>].</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Influenza virus surface glycoproteins</title><p>(<bold>A</bold>) Schematic diagram of an influenza virion, showing HA and NA (provided by CDC Influenza Division/Douglas Jordan/Dan Higgins). (<bold>B</bold>) Structure of HA (top and bottom rows) and NA (middle row) showing NLG sites for early (left columns) and recent (right column) isolates of A(H3N2) and A(H1N1) IAV. &#x02018;Oseltamivir&#x02019; (in red) indicates the NA active site. Early A(H3N2) isolate: A/Hong Kong/1/1968(H3N2). Recent A(H3N2) isolate: A/Singapore/INFIMH-16-0019/2016(H3N2). Early A(H1N1) isolate: A/South Carolina/1/1918(H1N1). Recent A(H1N1)isolate: A/Brisbane/59/2007(H1N1).</p></caption><graphic xlink:href="bsr-39-bsr20171505-g1"/></fig><p>IAV HA and NA are antigenically variable, with 18 structural variants of IAV HA and 11 variants of NA have been identified [<xref rid="B31" ref-type="bibr">31</xref>]. IAV subtypes are named based on their HA and NA combinations. In the 20th and 21st centuries, most IAV-related diseases in humans have been caused by the A(H1N1), A(H2N2), and A(H3N2) subtypes. In 1918, the highly pathogenic pandemic A(H1N1) killed as many as 50&#x02013;100 million people [<xref rid="B32" ref-type="bibr">32</xref>]. In 1957, A(H1N1) was replaced by A(H2N2), and in 1968 the A(H3N2) strain caused a global pandemic associated with more than one million deaths [<xref rid="B33" ref-type="bibr">33</xref>]. In 1977 the A(H1N1) virus re-emerged and co-circulated with A(H3N2) until 2009, when the swine-origin A(H1N1) pandemic (A(H1N1)pdm09) IAV replaced the older, antigenically distinct human seasonal A(H1N1) strain. Humans are also sporadically infected with highly and low pathogenic avian influenza A viruses, particularly H5, H9, and H7 HA subtypes. As yet, these viruses do not efficiently spread from person to person.</p><p>The surface glycoproteins of IAV, especially HA, are very tolerant of amino acid variations [<xref rid="B34" ref-type="bibr">34</xref>], allowing them to accumulate mutations that alter their antigenic nature. As IAV circulates in humans, HA and to a lesser extent NA [<xref rid="B34" ref-type="bibr">34</xref>] are therefore able to undergo repeated antigenic changes in response to population immunity. This &#x02018;antigenic drift&#x02019; presents a public health challenge because of the need to adjust the composition of seasonal vaccine in most years to provide protection against newly circulating antigenic variants. In contrast with IAV, IBV do not have subtypes of HA and NA. Influenza B viruses were first identified in the 1940s, and in the 1980s evolved into two genetically and antigenically distinct lineages, the B/Victoria/2/87 and the B/Yamagata/16/88 lineages. Co-circulation of both influenza B virus lineages with influenza A(H3N2) and A(H1N1) viruses during seasonal epidemics has prompted the development of quadrivalent vaccines that include strains from both subtypes of IAV and both influenza B lineages.</p></sec><sec id="sec3"><title>Influenza virus glycosylation</title><p>As well as simple amino acid changes, antigenic drift often involves changes in influenza virus HA and NA glycosylation patterns that shield or expose particular antigenic sites on these glycoproteins [<xref rid="B35" ref-type="bibr">35</xref>]. Host&#x02013;cell dependent glycosylation is a critical post-translational modification of influenza virus HA and NA. Glycosylation in the HA stalk region is important for protein folding and trafficking and for pH stability [<xref rid="B36" ref-type="bibr">36&#x02013;38</xref>], while the extent of glycosylation near the HA receptor-binding site alters its affinity for SA-containing receptors [<xref rid="B39" ref-type="bibr">39&#x02013;41</xref>]. Glycosylation near the cleavage HA site also modulates virus pathogenicity [<xref rid="B42" ref-type="bibr">42</xref>,<xref rid="B43" ref-type="bibr">43</xref>]. While the role of glycosylation of NA is less well understood, N-linked glycosylation is important for functional NA [<xref rid="B44" ref-type="bibr">44</xref>], and lack of NA glycosylation increases neurovirulence of the A/WSN/33 IAV strain in mice [<xref rid="B45" ref-type="bibr">45</xref>].</p><p>Glycosylation of HA and NA occurs through attachment of an oligosaccharide molecule to the side-chain amide nitrogen of Asn in the context of the conserved N-linked glycosylation (NLG) sequon Asn-X-Ser/Th, where X may represent any amino acid except Pro [<xref rid="B46" ref-type="bibr">46</xref>]. This attachment occurs with the help of glycosyltransferases and oligosaccharyltransferase in the endoplasmic reticulum (ER) and is followed by a complex process of trimming and remodeling of the oligosaccharides by glycosidases and mannosidases during transit through the ER and Golgi. This process results in a glycoprotein whose N-linked oligosaccharides branched structures terminate in mannose (high-mannose glycans), galactose and/or N-acetyl-galactosamine/fucose (complex glycans), or a combination (hybrid glycans) [<xref rid="B47" ref-type="bibr">47</xref>,<xref rid="B48" ref-type="bibr">48</xref>]. Some influenza virus HA and NA NLG sites may contain predominantly high-mannose glycans as the result of steric hindrance preventing access to the glycosyltransferases [<xref rid="B49" ref-type="bibr">49</xref>]. In contrast with cellular proteins, the complex oligosaccharides on influenza virus HA and NA are typically not sialylated, since NA removes the terminal SA [<xref rid="B50" ref-type="bibr">50</xref>]. To date, NLG is the only type of glycosylation observed for influenza virus HA and NA: there has been no O-linked (i.e. attachment of a sugar molecule to the hydroxyl group of Ser or Thr on the polypeptide chain) or C-linked (i.e. attachment of a sugar to a carbon group on a Trp side-chain) glycosylation reported for influenza virus.</p><sec id="sec3-1"><title>Techniques for influenza glycoprotein analysis</title><p>The simplest way to predict NLG addition is to identify a sequon, Asn-X-Ser/Thr, within the primary glycoprotein amino acid sequence. However, not all sequons are fully or even partially occupied, for various reasons including amino acid sequence [<xref rid="B51" ref-type="bibr">51&#x02013;53</xref>] and the specific cell type infected by the virus. Amino acid sequence also does not allow accurate prediction of the nature of the glycans added to different sites [<xref rid="B54" ref-type="bibr">54</xref>]. Approaches for more detailed analysis of influenza virus NLG have been comprehensively described in a recent review [<xref rid="B55" ref-type="bibr">55</xref>]. Briefly, these approaches can be divided into two major groups: those providing information on the nature and relative abundance of the glycoforms present on a glycoprotein, and those that further determine the degree to which each sequon is actually occupied by glycans. The first group of methods requires the initial release of glycans from the glycoproteins (e.g. by using hydrazine or the enzymes PNGase F and PNGase A) followed by mass spectrometry (MS) [<xref rid="B56" ref-type="bibr">56&#x02013;58</xref>] or high-performance liquid chromatography [<xref rid="B59" ref-type="bibr">59</xref>,<xref rid="B60" ref-type="bibr">60</xref>] for analysis of the released glycoforms. The second group of methods for NLG analysis involves immobilization of glycoproteins (using lectins or periodate-treated glycopeptides linked to hydrazide-activated beads) prior to enzymatic treatment with PNGaseF [<xref rid="B61" ref-type="bibr">61&#x02013;63</xref>]. During the process of glycan release, the Asn-X-Thr/Ser sequence converts to Asp-X-Thr/Ser, resulting in a mass difference. Subsequent MS/MS analysis of the eluted peptides allow identification of the glycosylated sites. Determination of precise glycoforms present at specific glycosites on intact glycoprotein consists of a complex of various techniques and procedures including sophisticated fragmentation by collision-induced dissociation, or high-energy collision dissociation, or electron-transfer dissociation [<xref rid="B61" ref-type="bibr">61</xref>,<xref rid="B64" ref-type="bibr">64&#x02013;67</xref>].</p><p>Although techniques for comprehensive site-specific characterization of NLG exist and have allowed biochemical verification of the glycans&#x02019; presence and their relative abundance at some sites of IAV and IBV glycoproteins [<xref rid="B54" ref-type="bibr">54</xref>,<xref rid="B68" ref-type="bibr">68&#x02013;72</xref>], until recently they represented a substantial analytical challenge. In 2018, Cao L. et al. [<xref rid="B73" ref-type="bibr">73</xref>] published a much less elaborate protocol for a semiquantitative MS-based method that promises to determine the degree of glycan occupancy at each glycosite and the proportion of N-glycans processed from high-mannose type to complex type. Introduction of this protocol into the ordinary practice of influenza laboratory will improve understanding of glycosylation-associated scientific data.</p></sec><sec id="sec3-2"><title>Evolutionary dynamics of influenza virus HA and NA N-linked glycosylation</title><p>Contemporary human influenza virus strains have circulated in human populations for many decades, undergoing selection for resistance to human immunity as well as enhanced transmission during that period. Glycosylation of influenza virus HA, especially for A(H3N2) viruses, has been shown to have a major impact on antigenicity and is an important factor in antigenic drift [<xref rid="B74" ref-type="bibr">74</xref>]. However, increasing glycosylation of HA molecule has also been correlated with decreased virulence, a change in tropism from the lower to the upper RT, and diminished enhancement of secondary bacterial lung infections [<xref rid="B75" ref-type="bibr">75</xref>]. This suggests that increasing levels of glycosylation may both enhance influenza immune evasion in the presence of population adaptive immunity, and also reduce viral virulence or replication ability in non-immune individuals.</p><p>Different influenza strains have shown different patterns of glycosylation in their major surface proteins [<xref rid="B76" ref-type="bibr">76</xref>]. The HA of A(H3N2) IAV has shown a strong trend toward increasing numbers of glycans since its introduction into the human population in 1968 (<xref ref-type="fig" rid="F2">Figure 2</xref>A,B). While the glycans on the stalk region have been quite constant for the past 50 years with five NLG sites at residues 24, 38, 54, 301, and 499 (numbering is based on the full-length protein), the globular head has undergone dramatic glycosylation modifications resulting in the loss and, more often, in the gain of glycosylation. The number of NLG sites on the influenza virus HA globular head has increased from two (at residues 97 and 181; site 97 was lost around 1975) on pandemic A(H3N2) IAV to up to nine (at residues 79, 97, 138, 142, 149, 160, 174, 181, and 262) on contemporary seasonal strains. The only new NLG site that has been acquired outside of the globular head was at residue 61, located between stalk and head regions.</p><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Evolution of influenza virus <italic>N-</italic>linked glycosylation</title><p>(<bold>A</bold>) Mean number per year of N-linked glycosylation (NLG) sites on the head and HA2 stem regions of HA, and on NA, from human isolates of A(H1N1) and A(H3N2), and B-Yamagata and B-Victoria lineages. (<bold>B</bold>) Residues of HA and NA from human A(H1N1) and A(H3N2) isolates on which more than 10% of isolates contained NLG. HA and NA sequences from human A(H1N1) and A(H3N2) isolates were downloaded from GISAID on September 6, 2018, manually curated to remove duplicates and laboratory variants, and aligned using MAFFT. Sites of potential NLG were identified based on sequence. The residue indicated as &#x02018;23a&#x02019; in A(H3N2) represents an insert relative to earlier HA isolates that was present in some viruses isolated in the 1970s. A(H1N1) viruses did not circulate among humans between 1957 and 1976, and those years are not shown. In 2009, indicated by red dashed lines, circulating seasonal A(H1N1) viruses were replaced by a novel pandemic A(H1N1)pdm09 strain. Influenza B viruses split into B-Yamagata and B-Victoria lineages in around 1983 [<xref rid="B180" ref-type="bibr">180</xref>]. Influenza B isolates from before 1983 are included in the charts for both lineages, and the date of divergence is indicated with blue dashed lines.</p></caption><graphic xlink:href="bsr-39-bsr20171505-g2"/></fig><p>The 1918 pandemic A(H1N1) IAV HA had six NLG sites (at residues 27, 28, 40, 304, 498, and 557) within the stalk region and only one (at residue 104) on the globular head of HA (<xref ref-type="fig" rid="F2">Figure 2</xref>A,B). As with A(H3N2), the NLG sites on the HA stalk region of A(H1N1) IAV have been highly conserved, and subsequent glycan losses and gains have occurred within the globular head only. Like A(H3N2), A(H1N1) IAV showed a trend toward increasing glycan number on the globular head until its elimination in 1957 (<xref ref-type="fig" rid="F2">Figure 2</xref>A), but after re-emerging in 1977 the number of glycans remained roughly constant until the virus was replaced by the 2009 A(H1N1)pdm09 pandemic virus (indicated with red dashed lines in <xref ref-type="fig" rid="F2">Figure 2</xref>). This strain had evolved within swine for many decades and was antigenically and genetically more similar to very early human A(H1N1) strains than to the human seasonal A(H1N1) strains that it replaced. The number of NLG sites on human IBV HA has remained fairly constant at 10&#x02013;12 sites since the split of Yamagata and Victoria lineages (<xref ref-type="fig" rid="F2">Figure 2</xref>A,B) (indicated with blue dashed lines in <xref ref-type="fig" rid="F2">Figure 2</xref>).</p><p>Changes in NA glycosylation have been less dramatic than in the HA. The 1918 pandemic A(H1N1) IAV NA had four NLG sites within the stalk region (at residues 50, 58, 63, and 68) and three within the globular head (at residues 88, 146, and 235) (<xref ref-type="fig" rid="F2">Figure 2</xref>A,B). While the stalk region of human IAV N1 maintained a roughly constant number of NLG sites, with sites 50 and 68 being replaced by those at residues 44 and 70, the globular head transiently added NLG at sites 365, 434, and 454. Similarly, the NA from A(H3N2) IAV and IBV have not shown obvious trends for increasing glycan count (<xref ref-type="fig" rid="F2">Figure 2</xref>A,B).</p></sec></sec><sec id="sec4"><title>Influenza glycosylation and innate immune responses</title><p>As well as modulating recognition of glycoproteins by the adaptive immune system, glycans on influenza viruses are also important for interactions with the innate immune response. Innate responses are the first line of host defense against viral infection. This system relies on recognition of pathogen-associated molecular properties (PAMPs) that distinguish pathogen molecules from those of the host. For example, terminal mannose residues are features of influenza virus HA and NA, but are not typical of human glycoproteins. When such PAMPs are detected, host pattern recognition receptors (PRRs) are activated, leading to downstream effects that limit pathogen replication, recruit more innate immune cells, and induce and amplify adaptive immune responses, as outlined in detail in a recent review [<xref rid="B77" ref-type="bibr">77</xref>]. Although many antiviral PRRs are intracellular, a number of cell-surface and soluble molecules act as antiviral PRRs, and some of these are lectins (proteins containing carbohydrate or fibrinogen recognition domains [CRD and FBG, respectively]) that generate an antiviral effect through binding to either mannose, fucose or galactose derivatives on influenza virus HA and NA [<xref rid="B78" ref-type="bibr">78&#x02013;83</xref>]. The presence and nature of glycans on influenza virus glycoproteins therefore influence the innate immune response to these pathogens.</p><sec id="sec4-1"><title>C-type lectins</title><p>Lectins that require calcium for binding are called C-type lectins [<xref rid="B81" ref-type="bibr">81</xref>,<xref rid="B84" ref-type="bibr">84</xref>]. These lectins can be present in serum and respiratory secretions as soluble molecules (collectins) or expressed on the surface of innate immune cells (endocytic lectins). The structure of a typical collectin includes an N-terminal cysteine-rich domain, a collagen-like domain (CLD), a neck region, and a CRD responsible for ligand binding [<xref rid="B85" ref-type="bibr">85</xref>]. Collectins include surfactant protein D (SP-D) and mannose-binding lectin (MBL), both of which have anti-influenza activity. Endocytic lectins implicated in anti-influenza activity include macrophage mannose receptor (MMR), macrophage galactose-type lectin (MGL), and DCs specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN).</p><sec id="sec4-1-1"><title>Soluble C-type lectins (collectins)</title><p>SP-D is well conserved among mammals. It is synthesized by type II pneumocytes and is mainly present in pulmonary surfactant (the lipoprotein substance of the air&#x02013;liquid interface in the alveoli of the lungs) of mammals including mice, ferrets, and humans [<xref rid="B84" ref-type="bibr">84</xref>]. It is also present in tear fluid of mice and humans and probably other mammals [<xref rid="B86" ref-type="bibr">86</xref>,<xref rid="B87" ref-type="bibr">87</xref>]. SP-D monomers (&#x0223c;130 kDa each) assemble into a 520&#x000a0;kDa tetrameric form, and further oligomerization of up to eight tetramers can occur, depending on species [<xref rid="B88" ref-type="bibr">88</xref>].</p><p>MBL is a complement protein that is produced and secreted by liver hepatocytes, and it is normally detected in serum [<xref rid="B84" ref-type="bibr">84</xref>]. MBL monomers of &#x0223c;32 kDa oligomerize into trimeric to hexameric structures, with trimeric and tetrameric variants being the most usual physiological forms [<xref rid="B89" ref-type="bibr">89</xref>]. MBL is highly polymorphic in humans [<xref rid="B90" ref-type="bibr">90</xref>,<xref rid="B91" ref-type="bibr">91</xref>] resulting in variations in MBL serum levels [<xref rid="B92" ref-type="bibr">92</xref>], with &#x0223c;10&#x02013;30% of the global human population being MBL deficient [<xref rid="B93" ref-type="bibr">93</xref>]. Variations in MBL levels may contribute to individual responses and may partially explain inconsistent conclusions on the MBL role in infections. SP-D and MBL both preferentially bind mannose over the galactose-type sugars found on influenza virus HA and NA [<xref rid="B83" ref-type="bibr">83</xref>].</p><p>Both SP-D and MBL have been shown to protect against IAV infection in cell and animal models. SP-D has also shown the ability to neutralize IBV in tissue culture cells [<xref rid="B94" ref-type="bibr">94</xref>]. While the SP-D is recognized as a major component of the innate immune response to influenza, the role of MBL in protection against influenza is not as clear [<xref rid="B95" ref-type="bibr">95</xref>]. Different strains of influenza seem to have widely varying susceptibilities to SP-D and MBL, and at least part of this may be related to the number, location, and composition of glycans on HA. As noted above, reduced morbidity, mortality, and viral lung titers in mice and ferrets were observed with A(H1N1) and A(H3N2) IAV as the level of HA glycosylation increased [<xref rid="B96" ref-type="bibr">96&#x02013;100</xref>]. Viruses that have low levels of glycosylation, such as the pandemic 1918 A(H1N1), 1957 A(H2N2), 1968 A(H3N2), and 2009 A(H1N1)pdm09 strains [<xref rid="B96" ref-type="bibr">96</xref>,<xref rid="B98" ref-type="bibr">98</xref>,<xref rid="B101" ref-type="bibr">101&#x02013;106</xref>] and the zoonotic A(H5N1) [<xref rid="B94" ref-type="bibr">94</xref>,<xref rid="B107" ref-type="bibr">107&#x02013;109</xref>] and A(H7N9) [<xref rid="B110" ref-type="bibr">110</xref>] strains, are relatively resistant to neutralization by SP-D and MBL in animal models, while highly glycosylated viruses are typically more susceptible [<xref rid="B98" ref-type="bibr">98</xref>,<xref rid="B111" ref-type="bibr">111&#x02013;113</xref>].</p><p>Studies in mice show a rise in SP-D level in airways during influenza infection with either A(H1N1) or A(H3N2) IAV [<xref rid="B96" ref-type="bibr">96</xref>]. SP-D knockout mice show enhanced viral replication, lung inflammation, and morbidity after influenza infection [<xref rid="B98" ref-type="bibr">98</xref>,<xref rid="B100" ref-type="bibr">100&#x02013;115</xref>], while expression of SP-D variants corrected the defects in A(H3N2) virus clearance and inflammatory responses [<xref rid="B97" ref-type="bibr">97</xref>]. However, mice are not natural hosts for influenza. Ferrets are considered to be a better model for human influenza infection [<xref rid="B116" ref-type="bibr">116</xref>], but the role of SP-D in the ferret model of influenza infection is less clear. Although SP-D appears to reduce replication of highly glycosylated A(H3N2) virus in ferrets [<xref rid="B104" ref-type="bibr">104</xref>,<xref rid="B111" ref-type="bibr">111</xref>], it may not be a major factor in this model [<xref rid="B105" ref-type="bibr">105</xref>].</p><p>In mice, MBL was present in bronchoalveolar lavage fluid by day 3 after infection with the mouse-adapted A(H1N1) strain A/Puerto Rico/8/1934 (PR8) [<xref rid="B96" ref-type="bibr">96</xref>]. MBL-knockout mice showed increased susceptibility to infection with a PR8 reassortant expressing the NA and NP segments and the highly glycosylated HA from the A(H3N2) strain A/Philippines/82 [<xref rid="B111" ref-type="bibr">111</xref>], but infection of MBL-deficient mice with A(H1N1)pdm09 or avian A(H9N2) strains, which are less heavily glycosylated, resulted in reduced severity and inflammation than in wild-type mice [<xref rid="B117" ref-type="bibr">117</xref>].</p><p>In humans, evidence that collectins protect against influenza is mainly indirect. Decreased SP-D expression in human lungs has been associated with fatal A(H5N1) influenza cases [<xref rid="B108" ref-type="bibr">108</xref>]. SP-D deficient groups such as smokers and people with chronic obstructive pulmonary disease, cystic fibrosis, and diabetes often suffer from more severe seasonal influenza disease [<xref rid="B118" ref-type="bibr">118&#x02013;121</xref>]. Reduced serum levels of MBL in children was correlated with enhanced severity of A(H1N1)pdm09 infection [<xref rid="B122" ref-type="bibr">122</xref>].</p><p>Collectins protect against influenza infection by several mechanisms. Direct binding to mannose residues on IAV HA [<xref rid="B123" ref-type="bibr">123</xref>,<xref rid="B124" ref-type="bibr">124</xref>] and NA [<xref rid="B82" ref-type="bibr">82</xref>] blocks virus&#x02013;receptor interactions and entry and leads to aggregation of viral particles. As well, formation of collectin&#x02013;virus complexes enhances phagocytosis and modulates inflammatory responses [<xref rid="B82" ref-type="bibr">82</xref>,<xref rid="B101" ref-type="bibr">101</xref>,<xref rid="B123" ref-type="bibr">123&#x02013;127</xref>]. Collectins inhibit influenza virus NA activity not only through direct binding to glycoprotein, but also through steric hindrance of the NA active site by lectins bound to glycans on HA [<xref rid="B82" ref-type="bibr">82</xref>,<xref rid="B96" ref-type="bibr">96</xref>,<xref rid="B123" ref-type="bibr">123</xref>].</p><p>While SP-D is generally anti-inflammatory [<xref rid="B128" ref-type="bibr">128</xref>,<xref rid="B129" ref-type="bibr">129</xref>], MBL is mainly a pro-inflammatory protein. After binding to pathogens, MBL can activate the lectin complement pathway via MBL-associated serine proteases, leading to complement-mediated lysis and/or opsonophagocytosis [<xref rid="B130" ref-type="bibr">130</xref>,<xref rid="B131" ref-type="bibr">131</xref>]. MBL may therefore act through both complement-dependent and independent mechanisms to neutralize influenza virus [<xref rid="B111" ref-type="bibr">111</xref>,<xref rid="B132" ref-type="bibr">132</xref>].</p><p>Glycosylation on specific residues of HA is associated with increased susceptibility to SP-D for some A(H3N2) and A(H1N1) IAV strains. The presence of an NLG site at residue 181 [<xref rid="B99" ref-type="bibr">99</xref>,<xref rid="B101" ref-type="bibr">101</xref>,<xref rid="B107" ref-type="bibr">107</xref>,<xref rid="B115" ref-type="bibr">115</xref>] or 262 [<xref rid="B99" ref-type="bibr">99</xref>] on the globular head of HA appears to be important for efficient neutralization of A(H3N2) IAV by SP-D, while glycosylation on residues 104, 142, and 293 may be important for A(H1N1) [<xref rid="B101" ref-type="bibr">101</xref>,<xref rid="B107" ref-type="bibr">107</xref>,<xref rid="B133" ref-type="bibr">133</xref>,<xref rid="B134" ref-type="bibr">134</xref>]. The importance of particular glycan sites for collectin sensitivity seems to depend on the extent of glycosylation. For example, A(H3N2) from the 1968 pandemic, which has lower levels of glycosylation, and current seasonal strains both contain an NLG site at residue 181. However, the 1968 strain is relatively resistant to both SP-D and MBL, while contemporary strains are sensitive [<xref rid="B96" ref-type="bibr">96</xref>,<xref rid="B98" ref-type="bibr">98</xref>].</p><p>Interactions between SP-D and its target glycans on viruses are influenced by glycan composition. Factors affecting the composition of glycans on influenza glycoproteins are not well understood, but may also be important for lectin-based inhibition [<xref rid="B135" ref-type="bibr">135</xref>,<xref rid="B136" ref-type="bibr">136</xref>].</p></sec><sec id="sec4-1-2"><title>Endocytic C-type lectins</title><p>Transmembrane C-type lectin receptors (CLRs) that recognize glycans of influenza virus HA and act as attachment/entry receptors are primarily expressed on alveolar and recruited macrophages, resident DCs, and B cells [<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B22" ref-type="bibr">22</xref>,<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B137" ref-type="bibr">137</xref>]. The importance of macrophages and DCs in host defense against IAV infection is well established [<xref rid="B138" ref-type="bibr">138</xref>,<xref rid="B139" ref-type="bibr">139</xref>]. Although it was thought that neither macrophages nor DCs can be productively infected with influenza virus, recent studies have shown productive infection of macrophages and DCs with A(H5N1) HPAI as well as A(H1N1) and A(H3N2) [<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B140" ref-type="bibr">140&#x02013;143</xref>]. While seasonal influenza infection stimulates macrophage and DC chemokine and cytokine responses, leading to augmented immune responses, productive virus replication in these cell types may alter antiviral functions and enhance disease severity [<xref rid="B144" ref-type="bibr">144</xref>].</p><p>Transmembrane CLRs on macrophages include receptors that can recognize mannose, fucose, and <italic>N</italic>-acetyl-D-glycosamine (macrophage mannose receptor; MMR) or galactose (macrophage galactose-type lectin; MGL) on IAV [<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B22" ref-type="bibr">22</xref>]. As well, both macrophages and DCs have a receptor dendritic cell-specific ICAM3-grabbing integrin (DC-SIGN) for fucosylated and high-mannose oligosaccharides [<xref rid="B23" ref-type="bibr">23</xref>]. Alternative splicing generates several DC-SIGN isoforms, including both membrane-bound and soluble forms [<xref rid="B145" ref-type="bibr">145</xref>]. The role of soluble DC-SIGN in immune responses is not well understood. MMR and MGL are type I transmembrane proteins with several CRDs&#x000a0;or CRD-like domains, and DC-SIGN is a type II membrane protein with a short amino terminal cytoplasmic tail, a neck region, and a single CRD.</p><p>Several studies have confirmed calcium-dependent lectin-mediated interactions between influenza and macrophages [<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B22" ref-type="bibr">22</xref>,<xref rid="B25" ref-type="bibr">25</xref>] and DC [<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B23" ref-type="bibr">23</xref>]. Such interactions could lead to infection of macrophages and DC, activation of these cell types, or both. While there is no direct evidence that CLR interactions with influenza are important for macrophage and DC activation, binding to endocytic CLR enhanced IAV infection of these cells [<xref rid="B20" ref-type="bibr">20&#x02013;23</xref>,<xref rid="B25" ref-type="bibr">25</xref>]. For example, MMR or MGL on macrophages was shown to be principal co-receptors (along with SA-containing receptors) for A(H1N1) and A(H3N2) virus entry and infection [<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B25" ref-type="bibr">25</xref>]. DC-SIGN serves as an endocytic receptor for entry and infection with A(H1N1)pdm09 [<xref rid="B138" ref-type="bibr">138</xref>] and A(H3N2) IAV [<xref rid="B146" ref-type="bibr">146</xref>], and enhanced expression of DC-SIGN in activated B cells increases their susceptibility to HPAI A(H5N1) infection [<xref rid="B147" ref-type="bibr">147</xref>].</p><p>Virus uptake through CLRs depends on the level of influenza virus HA (but not NA) glycosylation [<xref rid="B22" ref-type="bibr">22</xref>]. Increased HA glycosylation, and glycosylation at specific positions, resulted in a higher level of influenza infection in both macrophages [<xref rid="B20" ref-type="bibr">20</xref>] and DCs [<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B133" ref-type="bibr">133</xref>]. Interaction between CLRs and glycans on HA may represent an important route for infection of macrophages and DCs immune cells with influenza viruses.</p></sec><sec id="sec4-1-3"><title>Galectins</title><p>The galectins constitute a family of soluble, primarily mammalian, C-type lectins that are produced by various tissues, including airway epithelium and immune cells [<xref rid="B148" ref-type="bibr">148</xref>]. They are typically between 14 and 35&#x000a0;kDa and contain a conserved CRD of about 130 amino acids that exclusively bind &#x003b2;-galactosides (such as lactose [Gal&#x003b2;(1&#x02013;4)Glc] and N-acetyllactosamine [Gal&#x003b2;(1&#x02013;4)GlcNAc]) [<xref rid="B148" ref-type="bibr">148</xref>] of influenza virus HA. Currently, 15 galectins have been identified in mammals, although only galectins -1 through -10, -12 and -13 (Gal -1 &#x02013; Gal-10, Gal-12, and Gal-13) are found in humans [<xref rid="B149" ref-type="bibr">149</xref>]. They have a wide range of functions including mediation of cell&#x02013;cell interactions, cell&#x02013;matrix adhesion, and transmembrane signaling.</p><p>The ability of galectins to bind terminal galactose residues on the surface of viruses (including influenza) and act as PRRs has been recently recognized [<xref rid="B150" ref-type="bibr">150</xref>,<xref rid="B151" ref-type="bibr">151</xref>]. The effect of galectins on influenza disease seems to depend on the type of galectin and on genetic variation as well as the virus strain. Gal-1 has been shown to inhibit A(H1N1), A(H2N2), A(H3N2), A(H5N2), A(H6N1), and A(H7N9) IAVs [<xref rid="B151" ref-type="bibr">151&#x02013;153</xref>], while Gal-3 enhanced A(H5N1)-induced pulmonary inflammation [<xref rid="B154" ref-type="bibr">154</xref>] and Gal-9 reduced immune responses to both A(H1N1) and A(H3N2) IAVs [<xref rid="B155" ref-type="bibr">155</xref>]. Genetic variants of human Gal-1 that encode higher lectin expression conferred more protection against A(H7N9) IAV infection [<xref rid="B153" ref-type="bibr">153</xref>]. Intranasal treatment with Gal-1 significantly enhanced survival of mice challenged with a lethal dose of A(H1N1) IAV, and GAL-1-knockout mice were more susceptible to infection. Enhancement of galectin expression by IAV&#x02013;infection was reported for both humans (Gal-9) [<xref rid="B156" ref-type="bibr">156</xref>] and mice (Gal-1 and Gal-3) [<xref rid="B152" ref-type="bibr">152&#x02013;154</xref>].</p><p>Interactions between IAV and galectins may also promote disease under some conditions. Human Gal-1 and -8 promote IAV adhesion to the surface of the target-cell without affecting the internalization stage [<xref rid="B157" ref-type="bibr">157</xref>], and binding of A(H1N1) IAV to Gal-1 and -3 enhanced virus adhesion to and productive infection of airway epithelial cells, and increased galectin-mediated adhesion of <italic>S. pneumoniae</italic> [<xref rid="B158" ref-type="bibr">158</xref>], suggesting a possible role for galectins in secondary bacterial infections following influenza.</p></sec><sec id="sec4-1-4"><title>Ficolins</title><p>Ficolins are a family of oligomeric soluble lectins with subunits consisting of CLD and fibrinogen-like domain (FBG) that are capable of interacting with glycans (including N-acetylglucosamine, fucose etc., but not mannose) on a variety of pathogens in both calcium-dependent and -independent ways [<xref rid="B159" ref-type="bibr">159</xref>]. Like MBL, ficolins initiate lectin-mediated complement activation. In humans, three types of ficolins (L, M, and H) have been described [<xref rid="B160" ref-type="bibr">160&#x02013;163</xref>]. Ficolins L and H are mainly expressed by liver hepatocytes, while ficolin M is expressed by lungs, monocytes, and spleen [<xref rid="B164" ref-type="bibr">164&#x02013;167</xref>]. H-ficolin is also expressed by type II alveolar and bronchial epithelial cells [<xref rid="B167" ref-type="bibr">167&#x02013;170</xref>]. H-ficolin in human serum and BALF, and a purified recombinant variant, were shown to bind to IAV, block its HA activity, and inhibit replication of pandemic and seasonal IAVs in cell cultures [<xref rid="B171" ref-type="bibr">171</xref>]. Other studies have shown that H-ficolin and M-ficolin can inhibit replication of seasonal IAV in human monocytes [<xref rid="B171" ref-type="bibr">171</xref>,<xref rid="B172" ref-type="bibr">172</xref>]. Human L-ficolin and an L-ficolin-like molecule in mice were shown to bind HA and NA and inhibit IAV-infection both in tissue culture cells and mice [<xref rid="B173" ref-type="bibr">173</xref>].</p></sec></sec></sec><sec id="sec5"><title>Concluding remarks</title><p>Lectins are ancient parts of the innate immune system that can bind glycans on viral glycoproteins, leading to direct viral neutralization and to priming the immune system to enhance viral clearance. Unlike most antibodies, lectins can bind to a wide range of influenza strains, making them attractive candidates for antiviral therapies.</p><p>For example, engineered human SP-D enhanced IAV binding and clearance and murine survival <italic>in vivo</italic> [<xref rid="B174" ref-type="bibr">174</xref>]. A recombinant fragment of human SP-D, containing only neck and CRD regions, showed ability to act as virus entry inhibitor as well as ability to down-regulate excessive virus-induced pro-inflammatory responses [<xref rid="B175" ref-type="bibr">175</xref>]. Recombinant porcine SP-D (either as the intact protein or as a fragment containing the neck and CRD only) inhibited IAV and IBV infection in epithelial cells of human trachea [<xref rid="B94" ref-type="bibr">94</xref>] and A(H3N2) IAV in <italic>ex vivo</italic> cultures of respiratory tract tissue [<xref rid="B176" ref-type="bibr">176</xref>,<xref rid="B177" ref-type="bibr">177</xref>], and was more effective than recombinant human SP-D.</p><p>MBL has also exhibited therapeutic potential with recombinant chimeric versions inhibiting IAV both <italic>in vitro</italic> (through complement activation and induction of viral aggregation [<xref rid="B178" ref-type="bibr">178</xref>]) and in mice (in part, by balancing cytokine and inflammatory responses [<xref rid="B179" ref-type="bibr">179</xref>]).</p><p>Despite the progress achieved in the field of influenza innate immunity in recent years, our understanding of the interactions between lectin, influenza, and host dynamics is incomplete. A better understanding of these relationships could lead to novel therapeutic and immunomodulatory approaches for the treatment of influenza disease.</p></sec></body><back><ack><p>We thank Dr Terry Tumpey of Influenza Division of National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention for helpful discussions. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention or funding agency.</p></ack><sec id="sec6" sec-type="COI-statement"><title>Competing Interests</title><p>The authors declare that there are no competing interests associated with the manuscript.</p></sec><glossary><title>Abbreviations</title><def-list list-content="abbreviations"><def-item><term>CLD</term><def><p>collagen-like domain</p></def></def-item><def-item><term>CLR</term><def><p>C-type lectin receptor</p></def></def-item><def-item><term>ER</term><def><p>endoplasmic reticulum</p></def></def-item><def-item><term>FBG</term><def><p>fibrinogen-like domain</p></def></def-item><def-item><term>HA</term><def><p>hemagglutinin</p></def></def-item><def-item><term>IAV</term><def><p>influenza A virus</p></def></def-item><def-item><term>IBV</term><def><p>influenza B virus</p></def></def-item><def-item><term>ICV</term><def><p>influenza C virus</p></def></def-item><def-item><term>MBL</term><def><p>mannose-binding lectin</p></def></def-item><def-item><term>MGL</term><def><p>macrophage galactose-type lectin</p></def></def-item><def-item><term>MMR</term><def><p>macrophage mannose receptor</p></def></def-item><def-item><term>NA</term><def><p>neuraminidase</p></def></def-item><def-item><term>NLG</term><def><p>N-linked glycosylation</p></def></def-item><def-item><term>PAMP</term><def><p>pathogen-associated molecular property</p></def></def-item><def-item><term>PRR</term><def><p>pattern recognition receptor</p></def></def-item><def-item><term>RT</term><def><p>respiratory tract</p></def></def-item><def-item><term>SP-D</term><def><p>surfactant protein D</p></def></def-item></def-list></glossary><ref-list><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morens</surname><given-names>D.M.</given-names></name>, <name><surname>Taubenberger</surname><given-names>J.K.</given-names></name>, <name><surname>Folkers</surname><given-names>G.K.</given-names></name> and <name><surname>Fauci</surname><given-names>A.S.</given-names></name></person-group> (<year>2010</year>) <article-title>Pandemic influenza&#x02019;s 500th anniversary</article-title>. <source>Clin. Infect. Dis.</source>
<volume>51</volume>, <fpage>1442</fpage>&#x02013;<lpage>1444</lpage>
<pub-id pub-id-type="doi">10.1086/657429</pub-id>
<?supplied-pmid 21067353?><pub-id pub-id-type="pmid">21067353</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname><given-names>R.G.</given-names></name>, <name><surname>Bean</surname><given-names>W.J.</given-names></name>, <name><surname>Corman</surname><given-names>O.T.</given-names></name>, <name><surname>Chambers</surname><given-names>T.M.</given-names></name> and <name><surname>Kawaoka</surname><given-names>Y.</given-names></name></person-group> (<year>1992</year>) <article-title>Evolution and ecology of influenza A viruses</article-title>. <source>Microbiol. Rev.</source>
<volume>56</volume>, <fpage>152</fpage>&#x02013;<lpage>179</lpage>
<?supplied-pmid 1579108?><pub-id pub-id-type="pmid">1579108</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCullers</surname><given-names>J.A.</given-names></name> and <name><surname>Hayden</surname><given-names>F.G.</given-names></name></person-group> (<year>2012</year>) <article-title>Fatal influenza B infections: time to reexamine influenza research priorities</article-title>. <source>J. Infect. Dis.</source>
<volume>205</volume>, <fpage>870</fpage>&#x02013;<lpage>872</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jir865</pub-id>
<?supplied-pmid 22291194?><pub-id pub-id-type="pmid">22291194</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>R.M.</given-names></name></person-group> (<year>1949</year>) <article-title>Studies on survival of influenza virus between epidemics and antigenic variants of the virus</article-title>. <source>Am. J. Public Health Nations Health</source>
<volume>39</volume>, <fpage>171</fpage>&#x02013;<lpage>178</lpage>
<pub-id pub-id-type="doi">10.2105/AJPH.39.2.171</pub-id>
<?supplied-pmid 18111593?><pub-id pub-id-type="pmid">18111593</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parrish</surname><given-names>C.R.</given-names></name>, <name><surname>Murcia</surname><given-names>P.R.</given-names></name> and <name><surname>Holmes</surname><given-names>E.C.</given-names></name></person-group> (<year>2015</year>) <article-title>Influenza virus reservoirs and intermediate hosts: dogs, horses, and new possibilities for influenza virus exposure to humans</article-title>. <source>J. Virol.</source>
<volume>89</volume>, <fpage>2990</fpage>&#x02013;<lpage>2994</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.03146-14</pub-id>
<?supplied-pmid 25540375?><pub-id pub-id-type="pmid">25540375</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osterhaus</surname><given-names>A.D.</given-names></name>, <name><surname>Rimmelzwaan</surname><given-names>G.F.</given-names></name>, <name><surname>Martina</surname><given-names>B.E.</given-names></name>, <name><surname>Bestebroer</surname><given-names>T.M.</given-names></name> and <name><surname>Fouchier</surname><given-names>R.A.</given-names></name></person-group> (<year>2000</year>) <article-title>Influenza B virus in seals</article-title>. <source>Science</source>
<volume>288</volume>, <fpage>1051</fpage>&#x02013;<lpage>1053</lpage>
<pub-id pub-id-type="doi">10.1126/science.288.5468.1051</pub-id>
<?supplied-pmid 10807575?><pub-id pub-id-type="pmid">10807575</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuanji</surname><given-names>G.</given-names></name>, <name><surname>Fengen</surname><given-names>J.</given-names></name> and <name><surname>Ping</surname><given-names>W.</given-names></name></person-group> (<year>1983</year>) <article-title>Isolation of influenza C virus from pigs and experimental infection of pigs with influenza C virus</article-title>. <source>J. Gen. Virol.</source>
<volume>64</volume>, <fpage>177</fpage>&#x02013;<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1099/0022-1317-64-1-177</pub-id>
<?supplied-pmid 6296296?><pub-id pub-id-type="pmid">6296296</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohwada</surname><given-names>K.</given-names></name>, <name><surname>Kitame</surname><given-names>F.</given-names></name> and <name><surname>Homma</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>) <article-title>Experimental infections of dogs with type C influenza virus</article-title>. <source>Microbiol. Immunol.</source>
<volume>30</volume>, <fpage>451</fpage>&#x02013;<lpage>460</lpage>
<pub-id pub-id-type="doi">10.1111/j.1348-0421.1986.tb02971.x</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubenberger</surname><given-names>J.K.</given-names></name> and <name><surname>Kash</surname><given-names>J.C.</given-names></name></person-group> (<year>2010</year>) <article-title>Influenza virus evolution, host adaptation, and pandemic formation</article-title>. <source>Cell Host Microbe</source>
<volume>7</volume>, <fpage>440</fpage>&#x02013;<lpage>451</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2010.05.009</pub-id>
<?supplied-pmid 20542248?><pub-id pub-id-type="pmid">20542248</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayward</surname><given-names>A.C.</given-names></name>, <name><surname>Fragaszy</surname><given-names>E.B.</given-names></name>, <name><surname>Bermingham</surname><given-names>A.</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Copas</surname><given-names>A.</given-names></name>, <name><surname>Edmunds</surname><given-names>W.J.</given-names></name></person-group>
<etal/> (<year>2014</year>) <article-title>Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study</article-title>. <source>Lancet Respir. Med.</source>
<volume>2</volume>, <fpage>445</fpage>&#x02013;<lpage>454</lpage>
<pub-id pub-id-type="doi">10.1016/S2213-2600(14)70034-7</pub-id>
<?supplied-pmid 24717637?><pub-id pub-id-type="pmid">24717637</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horby</surname><given-names>P.W.</given-names></name></person-group> (<year>2014</year>) <article-title>Community studies of influenza: new knowledge, new questions</article-title>. <source>Lancet Respir. Med.</source>
<volume>2</volume>, <fpage>430</fpage>&#x02013;<lpage>431</lpage>
<pub-id pub-id-type="doi">10.1016/S2213-2600(14)70053-0</pub-id>
<?supplied-pmid 24717636?><pub-id pub-id-type="pmid">24717636</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiris</surname><given-names>M.</given-names></name> and <name><surname>Yen</surname><given-names>H.L.</given-names></name></person-group> (<year>2014</year>) <article-title>Animal and human influenzas</article-title>. <source>Rev. Sci. Tech.</source>
<volume>33</volume>, <fpage>539</fpage>&#x02013;<lpage>553</lpage>
<pub-id pub-id-type="doi">10.20506/rst.33.2.2289</pub-id>
<?supplied-pmid 25707182?><pub-id pub-id-type="pmid">25707182</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Short</surname><given-names>K.R.</given-names></name>, <name><surname>Richard</surname><given-names>M.</given-names></name>, <name><surname>Verhagen</surname><given-names>J.H.</given-names></name>, <name><surname>van Riel</surname><given-names>D.</given-names></name>, <name><surname>Schrauwen</surname><given-names>E.J.A.</given-names></name>, <name><surname>van den Brand</surname><given-names>J.M.A.</given-names></name></person-group>
<etal/> (<year>2015</year>) <article-title>One health, multiple challenges: the inter-species transmission of influenza A virus</article-title>. <source>One Health</source>
<volume>1</volume>, <fpage>1</fpage>&#x02013;<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/j.onehlt.2015.03.001</pub-id>
<?supplied-pmid 26309905?><pub-id pub-id-type="pmid">26309905</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glezen</surname><given-names>P.W.</given-names></name>, <name><surname>Schmier</surname><given-names>J.K</given-names></name>, <name><surname>Kuehn</surname><given-names>C.M.</given-names></name>, <name><surname>Ryan</surname><given-names>K.J.</given-names></name> and <name><surname>Oxford</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>) <article-title>The burden of influenza B: a structured literature review <italic>Am</italic></article-title>. <source>J. Public Health</source>
<volume>103</volume>, <fpage>e43</fpage>&#x02013;<lpage>e51</lpage></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brottet</surname><given-names>E.</given-names></name>, <name><surname>Vandroux</surname><given-names>D.</given-names></name>, <name><surname>Gauzere</surname><given-names>B.A.</given-names></name>, <name><surname>Antok</surname><given-names>E.</given-names></name>, <name><surname>Jaffar-Bandjee</surname><given-names>M.C.</given-names></name>, <name><surname>Michault</surname><given-names>A.</given-names></name></person-group>
<etal/> (<year>2014</year>) <article-title>Influenza season in R&#x000e9;union dominated by influenza B virus circulation associated with numerous cases of severe disease, France, 2014</article-title>. <source>Euro Surveill.</source>
<volume>19</volume>, <?supplied-pmid 25306979?><pub-id pub-id-type="pmid">25306979</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glezen</surname><given-names>W.P.</given-names></name></person-group> (<year>2008</year>) <article-title>Clinical practice. Prevention and treatment of seasonal influenza</article-title>. <source>N. Engl. J. Med.</source>
<volume>359</volume>, <fpage>2579</fpage>&#x02013;<lpage>2585</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMcp0807498</pub-id>
<?supplied-pmid 19073977?><pub-id pub-id-type="pmid">19073977</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joosting</surname><given-names>A.C.</given-names></name>, <name><surname>Head</surname><given-names>B.</given-names></name>, <name><surname>Bynoe</surname><given-names>M.L.</given-names></name> and <name><surname>Tyrrell</surname><given-names>D.A.</given-names></name></person-group> (<year>1968</year>) <article-title>Production of common colds in human volunteers by influenza C virus</article-title>. <source>Br. Med. J.</source>
<volume>4</volume>, <fpage>153</fpage>&#x02013;<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1136/bmj.4.5624.153</pub-id>
<?supplied-pmid 5681050?><pub-id pub-id-type="pmid">5681050</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>P.F.</given-names></name>, <name><surname>Neumann</surname><given-names>G.</given-names></name> and <name><surname>Kawaoka</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>) <article-title>Orthomyxoviruses</article-title>. In <source>Fields Virology</source>, <edition>6th edn</edition> (<person-group person-group-type="editor"><name><surname>Knipe</surname><given-names>D.M.</given-names></name> and <name><surname>Howley</surname><given-names>P.M.</given-names></name></person-group>, eds), pp. <fpage>1186</fpage>&#x02013;<lpage>1243</lpage>, <publisher-name>Lippincott/The Williams &#x00026; Wilkins, a Wolters Kluwer business</publisher-name>, <publisher-loc>Philadelphia, PA</publisher-loc></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>G.N.</given-names></name> and <name><surname>D&#x02019;Souza</surname><given-names>B.L</given-names></name></person-group> (<year>1989</year>) <article-title>Receptor binding properties of human and animal H1 influenza virus isolates</article-title>. <source>Virology</source>
<volume>173</volume>, <fpage>317</fpage>&#x02013;<lpage>322</lpage>
<pub-id pub-id-type="doi">10.1016/0042-6822(89)90249-3</pub-id><pub-id pub-id-type="pmid">2815586</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reading</surname><given-names>P.C.</given-names></name>, <name><surname>Miller</surname><given-names>J.L.</given-names></name> and <name><surname>Anders</surname><given-names>E.M.</given-names></name></person-group> (<year>2000</year>) <article-title>Involvement of the mannose receptor in infection of macrophages by influenza virus</article-title>. <source>J. Virol.</source>
<volume>74</volume>, <fpage>5190</fpage>&#x02013;<lpage>5197</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.74.11.5190-5197.2000</pub-id>
<?supplied-pmid 10799594?><pub-id pub-id-type="pmid">10799594</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.-F.</given-names></name>, <name><surname>Huang</surname><given-names>J.C.</given-names></name>, <name><surname>Lee</surname><given-names>Y.-M.</given-names></name>, <name><surname>Liu</surname><given-names>S.-J.</given-names></name>, <name><surname>Chan</surname><given-names>Y.-J.</given-names></name>, <name><surname>Chau</surname><given-names>Y.-P.</given-names></name></person-group>
<etal/> (<year>2008</year>) <article-title>DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>373</volume>, <fpage>561</fpage>&#x02013;<lpage>566</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2008.06.078</pub-id>
<?supplied-pmid 18593570?><pub-id pub-id-type="pmid">18593570</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upham</surname><given-names>J.P.</given-names></name>, <name><surname>Pickett</surname><given-names>D.</given-names></name>, <name><surname>Irimura</surname><given-names>T.</given-names></name>, <name><surname>Anders</surname><given-names>E.M.</given-names></name> and <name><surname>Reading</surname><given-names>P.C.</given-names></name></person-group> (<year>2010</year>) <article-title>Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry</article-title>. <source>J. Virol.</source>
<volume>84</volume>, <fpage>3730</fpage>&#x02013;<lpage>3737</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.02148-09</pub-id>
<?supplied-pmid 20106926?><pub-id pub-id-type="pmid">20106926</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Londrigan</surname><given-names>S.L.</given-names></name>, <name><surname>Turville</surname><given-names>S.G.</given-names></name>, <name><surname>Tate</surname><given-names>M.D.</given-names></name>, <name><surname>Deng</surname><given-names>Y.M.</given-names></name>, <name><surname>Brooks</surname><given-names>A.G.</given-names></name> and <name><surname>Reading</surname><given-names>P.C.</given-names></name></person-group> (<year>2011</year>) <article-title>N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC&#x02013;SIGN or L&#x02013;SIGN</article-title>. <source>J. Virol.</source>
<volume>85</volume>, <fpage>2990</fpage>&#x02013;<lpage>3000</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.01705-10</pub-id>
<?supplied-pmid 21191006?><pub-id pub-id-type="pmid">21191006</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillaire</surname><given-names>M.L.B.</given-names></name>, <name><surname>Nieuwkoop</surname><given-names>N.J.</given-names></name>, <name><surname>Boon</surname><given-names>A.C.M.</given-names></name>, <name><surname>de Mutsert</surname><given-names>G.</given-names></name>, <name><surname>Vogelzangvan Trierum</surname><given-names>S.E.</given-names></name>, <name><surname>Fouchier</surname><given-names>R.A.M.</given-names></name></person-group>
<etal/> (<year>2013</year>) <article-title>Binding of DC-SIGN to the hemagglutinin of influenza A viruses supports virus replication in DC-SIGN expressing cells</article-title>. <source>PLoS One</source>
<volume>8</volume>, <fpage>e56164</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0056164</pub-id>
<?supplied-pmid 23424649?><pub-id pub-id-type="pmid">23424649</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>W.C.</given-names></name>, <name><surname>Liong</surname><given-names>S.</given-names></name>, <name><surname>Tate</surname><given-names>M.D.</given-names></name>, <name><surname>Irimura</surname><given-names>T.</given-names></name>, <name><surname>Denda-Nagai</surname><given-names>K.</given-names></name>, <name><surname>Brooks</surname><given-names>A.G.</given-names></name></person-group>
<etal/> (<year>2014</year>) <article-title>The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus</article-title>. <source>J. Virol.</source>
<volume>88</volume>, <fpage>1659</fpage>&#x02013;<lpage>1672</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.02014-13</pub-id>
<?supplied-pmid 24257596?><pub-id pub-id-type="pmid">24257596</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>W.C.</given-names></name>, <name><surname>Londrigan</surname><given-names>S.L.</given-names></name>, <name><surname>Nasr</surname><given-names>N.</given-names></name>, <name><surname>Cunningham</surname><given-names>A.L.</given-names></name>, <name><surname>Turville</surname><given-names>S.</given-names></name>, <name><surname>Brooks</surname><given-names>A.G.</given-names></name></person-group>
<etal/> (<year>2016</year>) <article-title>The C&#x02013;type lectin langerin functions as a receptor for attachment and infectious entry of influenza A virus</article-title>. <source>J. Virol.</source>
<volume>90</volume>, <fpage>206</fpage>&#x02013;<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.01447-15</pub-id>
<?supplied-pmid 26468543?><pub-id pub-id-type="pmid">26468543</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>T.</given-names></name>, <name><surname>Taylor</surname><given-names>G.</given-names></name> and <name><surname>Webster</surname><given-names>R.G.</given-names></name></person-group> (<year>1995</year>) <article-title>Steps in maturation of influenza virus neuraminidase</article-title>. <source>J. Virol.</source>
<volume>69</volume>, <fpage>5011</fpage>&#x02013;<lpage>5017</lpage>
<?supplied-pmid 7541844?><pub-id pub-id-type="pmid">7541844</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varghese</surname><given-names>J.N.</given-names></name> and <name><surname>Colman</surname><given-names>P.M</given-names></name></person-group> (<year>1991</year>) <article-title>Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 and 2.2 &#x001fa; resolution</article-title>. <source>J. Mol. Biol.</source>
<volume>221</volume>, <fpage>473</fpage>&#x02013;<lpage>486</lpage>
<pub-id pub-id-type="doi">10.1016/0022-2836(91)80068-6</pub-id>
<?supplied-pmid 1920428?><pub-id pub-id-type="pmid">1920428</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>M</given-names></name></person-group> (<year>2012</year>) <article-title>Influenza virus entry</article-title>. <source>Adv. Exp. Med. Biol.</source>
<volume>726</volume>, <fpage>201</fpage>&#x02013;<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4614-0980-9_9</pub-id>
<?supplied-pmid 22297515?><pub-id pub-id-type="pmid">22297515</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>M.</given-names></name>, <name><surname>Zhang</surname><given-names>X.Q.</given-names></name>, <name><surname>Senaati</surname><given-names>H.P.</given-names></name>, <name><surname>Chen</surname><given-names>H.W.</given-names></name>, <name><surname>Varki</surname><given-names>N.M.</given-names></name>, <name><surname>Schooley</surname><given-names>R.T.</given-names></name></person-group>
<etal/> (<year>2013</year>) <article-title>Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase</article-title>. <source>Virol</source>
<volume>10</volume>, <fpage>321</fpage>
<pub-id pub-id-type="doi">10.1186/1743-422X-10-321</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname><given-names>R.G.</given-names></name> and <name><surname>Govorkova</surname><given-names>E.A</given-names></name></person-group> (<year>2014</year>) <article-title>Continuing challenges in influenza</article-title>. <source>Ann. N.Y. Acad. Sci.</source>
<volume>1323</volume>, <fpage>115</fpage>&#x02013;<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1111/nyas.12462</pub-id>
<?supplied-pmid 24891213?><pub-id pub-id-type="pmid">24891213</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>N.P.</given-names></name> and <name><surname>Mueller</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>) <article-title>Updating the accounts: global mortality of the 1918-1920 &#x0201c;Spanish&#x0201d; influenza pandemic</article-title>. <source>Bull. Hist. Med.</source>
<volume>76</volume>, <fpage>105</fpage>&#x02013;<lpage>115</lpage>
<pub-id pub-id-type="doi">10.1353/bhm.2002.0022</pub-id>
<?supplied-pmid 11875246?><pub-id pub-id-type="pmid">11875246</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doshi</surname><given-names>P.</given-names></name></person-group> (<year>2008</year>) <article-title>Trends in recorded influenza mortality: United States, 1900-2004</article-title>. <source>Am. J. Public Health</source>
<volume>98</volume>, <fpage>939</fpage>&#x02013;<lpage>945</lpage>
<?supplied-pmid 18381993?><pub-id pub-id-type="pmid">18381993</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilbourne</surname><given-names>E.D.</given-names></name>, <name><surname>Johansson</surname><given-names>B.E</given-names></name> and <name><surname>Grajower</surname><given-names>B.</given-names></name></person-group> (<year>1990</year>) <article-title>Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>87</volume>, <fpage>786</fpage>&#x02013;<lpage>790</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.87.2.786</pub-id>
<?supplied-pmid 2300562?><pub-id pub-id-type="pmid">2300562</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>Y.</given-names></name></person-group> (<year>2005</year>) <article-title>Sialobiology of influenza: molecular mecjanism of host range variation of influenza viruses</article-title>. <source>Biol. Pharm. Bull.</source>
<volume>28</volume>, <fpage>399</fpage>&#x02013;<lpage>408</lpage>
<pub-id pub-id-type="doi">10.1248/bpb.28.399</pub-id>
<?supplied-pmid 15744059?><pub-id pub-id-type="pmid">15744059</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>P.C.</given-names></name>, <name><surname>Garten</surname><given-names>W.</given-names></name> and <name><surname>Klenk</surname><given-names>H.D.</given-names></name></person-group> (<year>1993</year>) <article-title>Role of conserved glycosylation sites in maturation and transport of influenza virus hemagglutinin</article-title>. <source>J. Virol.</source>
<volume>67</volume>, <fpage>3048</fpage>&#x02013;<lpage>3060</lpage>
<?supplied-pmid 8497042?><pub-id pub-id-type="pmid">8497042</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohuchi</surname><given-names>R.</given-names></name>, <name><surname>Ohuchi</surname><given-names>M.</given-names></name>, <name><surname>Garten</surname><given-names>W.</given-names></name> and <name><surname>Klenk</surname><given-names>H.D.</given-names></name></person-group> (<year>1997</year>) <article-title>Oligosaccharides in the stem region maintain the influenza virus hemagglutinin in the metastable form required for fusion activity</article-title>. <source>J. Virol.</source>
<volume>71</volume>, <fpage>3719</fpage>&#x02013;<lpage>3725</lpage>
<?supplied-pmid 9094646?><pub-id pub-id-type="pmid">9094646</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>E.</given-names></name>, <name><surname>Sugawara</surname><given-names>K.</given-names></name>, <name><surname>Hongo</surname><given-names>S.</given-names></name>, <name><surname>Matsuzaki</surname><given-names>Y.</given-names></name>, <name><surname>Muraki</surname><given-names>Y.</given-names></name> and <name><surname>Nakamura</surname><given-names>K.</given-names></name></person-group> (<year>2002</year>) <article-title>Role of overlapping glycosylation sequons in antigenic properties, intracellular transport and biological activities of influenza A/H2N2 virus hemagglutinin</article-title>. <source>J. Gen. Virol.</source>
<volume>83</volume>, <fpage>3067</fpage>&#x02013;<lpage>3074</lpage>
<pub-id pub-id-type="doi">10.1099/0022-1317-83-12-3067</pub-id>
<?supplied-pmid 12466483?><pub-id pub-id-type="pmid">12466483</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohuchi</surname><given-names>M.</given-names></name>, <name><surname>Ohuchi</surname><given-names>R.</given-names></name>, <name><surname>Feldmann</surname><given-names>A.</given-names></name> and <name><surname>Klenk</surname><given-names>H.D.</given-names></name></person-group> (<year>1997</year>) <article-title>Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety</article-title>. <source>J. Virol.</source>
<volume>71</volume>, <fpage>8377</fpage>&#x02013;<lpage>8377</lpage>
<?supplied-pmid 9343193?><pub-id pub-id-type="pmid">9343193</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gambaryan</surname><given-names>A.S.</given-names></name>, <name><surname>Marinina</surname><given-names>V.P.</given-names></name>, <name><surname>Tuzikov</surname><given-names>A.B.</given-names></name>, <name><surname>Bovin</surname><given-names>N.V.</given-names></name>, <name><surname>Rudneva</surname><given-names>I.A.</given-names></name>, <name><surname>Sinitsyn</surname><given-names>B.V.</given-names></name></person-group>
<etal/> (<year>1998</year>) <article-title>Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties of H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs</article-title>. <source>Virology</source>
<volume>247</volume>, <fpage>170</fpage>&#x02013;<lpage>177</lpage>
<pub-id pub-id-type="doi">10.1006/viro.1998.9224</pub-id><pub-id pub-id-type="pmid">9705910</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alymova</surname><given-names>I.V</given-names></name>, <name><surname>York</surname><given-names>I.A.</given-names></name>, <name><surname>Air</surname><given-names>G.M.</given-names></name>, <name><surname>Cipollo</surname><given-names>J.F.</given-names></name>, <name><surname>Gulati</surname><given-names>S.</given-names></name>, <name><surname>Baranovich</surname><given-names>T.</given-names></name></person-group>
<etal/> (<year>2016</year>) <article-title>Glycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulence</article-title>. <source>Sci. Rep.</source>
<volume>6</volume>, <fpage>36216</fpage>
<pub-id pub-id-type="doi">10.1038/srep36216</pub-id>
<?supplied-pmid 27796371?><pub-id pub-id-type="pmid">27796371</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshpande</surname><given-names>K.L.</given-names></name>, <name><surname>Fried</surname><given-names>V.A.</given-names></name>, <name><surname>Ando</surname><given-names>M.</given-names></name> and <name><surname>Webster</surname><given-names>R.G.</given-names></name></person-group> (<year>1987</year>) <article-title>Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>84</volume>, <fpage>36</fpage>&#x02013;<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.84.1.36</pub-id>
<?supplied-pmid 3467357?><pub-id pub-id-type="pmid">3467357</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohuchi</surname><given-names>M.</given-names></name>, <name><surname>Orlich</surname><given-names>M.</given-names></name>, <name><surname>Ohuchi</surname><given-names>R.</given-names></name>, <name><surname>Simpson</surname><given-names>B.E.</given-names></name>, <name><surname>Garten</surname><given-names>W.</given-names></name>, <name><surname>Klenk</surname><given-names>H.D.</given-names></name></person-group>
<etal/> (<year>1989</year>) <article-title>Mutations at the cleavage site of the hemagglutinin alter the pathogenicity of influenza virus A/chick/Penn/83 (H5N2)</article-title>. <source>Virology</source>
<volume>168</volume>, <fpage>274</fpage>&#x02013;<lpage>280</lpage>
<pub-id pub-id-type="doi">10.1016/0042-6822(89)90267-5</pub-id><pub-id pub-id-type="pmid">2916326</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>R.</given-names></name>, <name><surname>Wolff</surname><given-names>T.</given-names></name>, <name><surname>Herwig</surname><given-names>A.</given-names></name>, <name><surname>Pleschka</surname><given-names>S.</given-names></name> and <name><surname>Klenk</surname><given-names>H.D.</given-names></name></person-group> (<year>2000</year>) <article-title>Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics</article-title>. <source>J. Virol.</source>
<volume>74</volume>, <fpage>6316</fpage>&#x02013;<lpage>6323</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.74.14.6316-6323.2000</pub-id>
<?supplied-pmid 10864641?><pub-id pub-id-type="pmid">10864641</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.</given-names></name>, <name><surname>Schulman</surname><given-names>J.</given-names></name>, <name><surname>Itamura</surname><given-names>S.</given-names></name> and <name><surname>Palese</surname><given-names>P.</given-names></name></person-group> (<year>1993</year>) <article-title>Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus</article-title>. <source>J. Virol.</source>
<volume>67</volume>, <fpage>6667</fpage>&#x02013;<lpage>6673</lpage>
<?supplied-pmid 8411368?><pub-id pub-id-type="pmid">8411368</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kornfeld</surname><given-names>R.</given-names></name> and <name><surname>Kornfeld</surname><given-names>S.</given-names></name></person-group> (<year>1985</year>) <article-title>Assembly of asparagine-linked oligosaccharides</article-title>. <source>Annu. Rev. Biochem.</source>
<volume>54</volume>, <fpage>631</fpage>&#x02013;<lpage>664</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.bi.54.070185.003215</pub-id>
<?supplied-pmid 3896128?><pub-id pub-id-type="pmid">3896128</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basak</surname><given-names>S.</given-names></name>, <name><surname>Pritchard</surname><given-names>D.G.</given-names></name>, <name><surname>Bhown</surname><given-names>A.S.</given-names></name> and <name><surname>Compans</surname><given-names>R.W.</given-names></name></person-group> (<year>1981</year>) <article-title>Glycosylation sites of influenza viral glycoproteins: Characterization of tryptic glycoproteins from the A/USSR(H1N1) hemagglutinin protein</article-title>. <source>J. Virol.</source>
<volume>37</volume>, <fpage>549</fpage>&#x02013;<lpage>558</lpage>
<?supplied-pmid 7218432?><pub-id pub-id-type="pmid">7218432</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>C.W.</given-names></name> and <name><surname>Dopheide</surname><given-names>T.A.</given-names></name></person-group> (<year>1991</year>) <article-title>Amino acid sequence and oligosaccharide distribution of the haemagglutinin from an early Hong Kong influenza virus variant A/Aichi/2/68 (X-31)</article-title>. <source>Biochem. J.</source>
<volume>193</volume>, <fpage>953</fpage>&#x02013;<lpage>962</lpage>
<pub-id pub-id-type="doi">10.1042/bj1930953</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>F.</given-names></name> and <name><surname>Aebi</surname><given-names>M</given-names></name></person-group> (<year>2011</year>) <article-title>Mechanisms and principles of N-linked protein glycosylation</article-title>. <source>Curr. Opin. Struct. Biol.</source>
<volume>21</volume>, <fpage>576</fpage>&#x02013;<lpage>582</lpage>
<pub-id pub-id-type="doi">10.1016/j.sbi.2011.08.005</pub-id>
<?supplied-pmid 21978957?><pub-id pub-id-type="pmid">21978957</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basak</surname><given-names>S.</given-names></name>, <name><surname>Tomana</surname><given-names>M.</given-names></name> and <name><surname>Compans</surname><given-names>R.W.</given-names></name></person-group> (<year>1985</year>) <article-title>Sialic acid is incorporated into influenza hemagglutinin glycoproteins in the absence of viral neuraminidase</article-title>. <source>Virus Res.</source>
<volume>2</volume>, <fpage>61</fpage>&#x02013;<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1016/0168-1702(85)90060-7</pub-id>
<?supplied-pmid 3984493?><pub-id pub-id-type="pmid">3984493</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasturi</surname><given-names>L.</given-names></name>, <name><surname>Eshleman</surname><given-names>J.R.</given-names></name>, <name><surname>Wunner</surname><given-names>W.H.</given-names></name> and <name><surname>Shakin-Eshleman</surname><given-names>S.H.</given-names></name></person-group> (<year>1995</year>) <article-title>The hydroxy amino acid in Asn-X-Ser/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein</article-title>. <source>J. Biol. Chem.</source>
<volume>270</volume>, <fpage>14756</fpage>&#x02013;<lpage>14761</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.270.24.14756</pub-id>
<?supplied-pmid 7782341?><pub-id pub-id-type="pmid">7782341</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellquist</surname><given-names>J.L.</given-names></name>, <name><surname>Kasturi</surname><given-names>L.</given-names></name>, <name><surname>Spitalnik</surname><given-names>S.L.</given-names></name> and <name><surname>Shakin-Eshleman</surname><given-names>S.H.</given-names></name></person-group> (<year>1998</year>) <article-title>The amino acid following an Asn-X-Ser/Thr sequin is an important determinant of N-linked core glycosylation efficiency</article-title>. <source>Biochem.</source>
<volume>37</volume>, <fpage>6833</fpage>&#x02013;<lpage>6837</lpage>
<pub-id pub-id-type="doi">10.1021/bi972217k</pub-id><pub-id pub-id-type="pmid">9578569</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blake</surname><given-names>T.A.</given-names></name>, <name><surname>Williams</surname><given-names>T.L</given-names></name>, <name><surname>Pirkle</surname><given-names>J.L.</given-names></name> and <name><surname>Barr</surname><given-names>J.R.</given-names></name></person-group> (<year>2009</year>) <article-title>Targeted N-linked glycosylation analysis of H5N1 influenza hemagglutinin by selective sample preparation and liquid chromatography/tandem mass spectrometry</article-title>. <source>Anal. Chem.</source>
<volume>81</volume>, <fpage>3109</fpage>&#x02013;<lpage>3118</lpage>
<pub-id pub-id-type="doi">10.1021/ac900095h</pub-id>
<?supplied-pmid 19290601?><pub-id pub-id-type="pmid">19290601</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>Y.</given-names></name>, <name><surname>McCullers</surname><given-names>J.A.</given-names></name>, <name><surname>Alymova</surname><given-names>I.</given-names></name>, <name><surname>Parson</surname><given-names>L.M.</given-names></name> and <name><surname>Cipollo</surname><given-names>J.F.</given-names></name></person-group> (<year>2015</year>) <article-title>Glycosylation analysis of engineered H3N2 influenza A virus hemagglutinins with sequentially added historically relevant glycosylation sites</article-title>. <source>J. Proteome Res.</source>
<volume>14</volume>, <fpage>3957</fpage>&#x02013;<lpage>3969</lpage>
<pub-id pub-id-type="doi">10.1021/acs.jproteome.5b00416</pub-id>
<?supplied-pmid 26202417?><pub-id pub-id-type="pmid">26202417</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>D.J.</given-names></name></person-group> (<year>2018</year>) <article-title>Mass spectrometric analysis of glycosylated viral proteins</article-title>. <source>Expert Rev. Proteomic.</source>
<volume>15</volume>, <fpage>391</fpage>&#x02013;<lpage>412</lpage>
<pub-id pub-id-type="doi">10.1080/14789450.2018.1468756</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashline</surname><given-names>D.</given-names></name>, <name><surname>Singh</surname><given-names>S.</given-names></name>, <name><surname>Hanneman</surname><given-names>A.</given-names></name> and <name><surname>Reinhold</surname><given-names>V.</given-names></name></person-group> (<year>2005</year>) <article-title>Congruent strategies for carbohydrate sequencing. 1. Mining structural details by MSn</article-title>. <source>Anal. Chem.</source>
<volume>77</volume>, <fpage>6250</fpage>&#x02013;<lpage>6262</lpage>
<pub-id pub-id-type="doi">10.1021/ac050724z</pub-id>
<?supplied-pmid 16194086?><pub-id pub-id-type="pmid">16194086</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaia</surname><given-names>J</given-names></name></person-group> (<year>2008</year>) <article-title>Mass spectrometry and the emerging field of glycomics</article-title>. <source>Chem. Biol.</source>
<volume>15</volume>, <fpage>881</fpage>&#x02013;<lpage>892</lpage>
<pub-id pub-id-type="doi">10.1016/j.chembiol.2008.07.016</pub-id>
<?supplied-pmid 18804025?><pub-id pub-id-type="pmid">18804025</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolarich</surname><given-names>D.</given-names></name>, <name><surname>Jensen</surname><given-names>P.H.</given-names></name>, <name><surname>Altmann</surname><given-names>F.</given-names></name> and <name><surname>Packer</surname><given-names>N.H.</given-names></name></person-group> (<year>2012</year>) <article-title>Determination of site-specific glycan heterogeneity on glycoproteins</article-title>. <source>Nat. Protoc.</source>
<volume>7</volume>, <fpage>1285</fpage>&#x02013;<lpage>1298</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2012.062</pub-id>
<?supplied-pmid 22678432?><pub-id pub-id-type="pmid">22678432</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bones</surname><given-names>J.</given-names></name>, <name><surname>Mittermayr</surname><given-names>S.</given-names></name>, <name><surname>O&#x02019;Donoghue</surname><given-names>N.</given-names></name>, <name><surname>Guttman</surname><given-names>A.</given-names></name> and <name><surname>Rudd</surname><given-names>P.M.</given-names></name></person-group> (<year>2010</year>) <article-title>Ultra performance liquid chromatographic profiling of serum N-Glycans for fast and efficient identification of cancer associated alterations in glycosylation</article-title>. <source>Anal. Chem.</source>
<volume>82</volume>, <fpage>10208</fpage>&#x02013;<lpage>10215</lpage>
<pub-id pub-id-type="doi">10.1021/ac102860w</pub-id>
<?supplied-pmid 21073175?><pub-id pub-id-type="pmid">21073175</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zauner</surname><given-names>G.</given-names></name>, <name><surname>Deelder</surname><given-names>A.M.</given-names></name> and <name><surname>Wuhrer</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>) <article-title>Recent advances in hydrophilic interaction liquid chromatography (HILIC) for structural glycomics</article-title>. <source>Electrophor.</source>
<volume>32</volume>, <fpage>3456</fpage>&#x02013;<lpage>3466</lpage>
<pub-id pub-id-type="doi">10.1002/elps.201100247</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaji</surname><given-names>H.</given-names></name>, <name><surname>Saito</surname><given-names>H.</given-names></name>, <name><surname>Yamauchi</surname><given-names>Y.</given-names></name>, <name><surname>Shinkawa</surname><given-names>T.</given-names></name>, <name><surname>Taoka</surname><given-names>M.</given-names></name>, <name><surname>Hirabayashi</surname><given-names>J.</given-names></name></person-group>
<etal/> (<year>2003</year>) <article-title>Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins</article-title>. <source>Nat. Biotechnol.</source>
<volume>21</volume>, <fpage>667</fpage>&#x02013;<lpage>672</lpage>
<pub-id pub-id-type="doi">10.1038/nbt829</pub-id>
<?supplied-pmid 12754521?><pub-id pub-id-type="pmid">12754521</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name>, <name><surname>Li</surname><given-names>X.J.</given-names></name>, <name><surname>Martin</surname><given-names>D.B.</given-names></name> and <name><surname>Aebersold</surname><given-names>R.</given-names></name></person-group> (<year>2003</year>) <article-title>Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry</article-title>. <source>Nat. Biotechnol.</source>
<volume>21</volume>, <fpage>660</fpage>&#x02013;<lpage>666</lpage>
<pub-id pub-id-type="doi">10.1038/nbt827</pub-id>
<?supplied-pmid 12754519?><pub-id pub-id-type="pmid">12754519</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wada</surname><given-names>Y.</given-names></name>, <name><surname>Tajiri</surname><given-names>M.</given-names></name> and <name><surname>Yoshida</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>) <article-title>Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics</article-title>. <source>Anal. Chem.</source>
<volume>76</volume>, <fpage>6560</fpage>&#x02013;<lpage>6565</lpage>
<pub-id pub-id-type="doi">10.1021/ac049062o</pub-id>
<?supplied-pmid 15538777?><pub-id pub-id-type="pmid">15538777</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>L.</given-names></name>, <name><surname>Yu</surname><given-names>L.</given-names></name>, <name><surname>Guo</surname><given-names>Z.</given-names></name>, <name><surname>Shen</surname><given-names>A.</given-names></name>, <name><surname>Guo</surname><given-names>Y.</given-names></name> and <name><surname>Liang</surname><given-names>X.</given-names></name></person-group> (<year>2014</year>) <article-title>N-glycosylation site analysis of proteins from <italic>Saccharomyces cerevisiae</italic> by using hydrophilic interaction liquid chromatography-based enrichment, parallel deglycosylation, and mass spectrometry</article-title>. <source>J. Proteome Res.</source>
<volume>13</volume>, <fpage>1485</fpage>&#x02013;<lpage>1493</lpage>
<pub-id pub-id-type="doi">10.1021/pr401049e</pub-id>
<?supplied-pmid 24527708?><pub-id pub-id-type="pmid">24527708</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khatri</surname><given-names>K.</given-names></name>, <name><surname>Klein</surname><given-names>J.A.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name>, <name><surname>Grant</surname><given-names>O.C.</given-names></name>, <name><surname>Leymarie</surname><given-names>N.</given-names></name>, <name><surname>Woods</surname><given-names>R.J.</given-names></name></person-group>
<etal/> (<year>2016</year>) <article-title>Integrated omics and computational glycobiology reveal structural basis for influenza A virus glycan microheterogeneity and host interactions</article-title>. <source>Mol. Cell. Proteomics</source>
<volume>15</volume>, <fpage>1895</fpage>&#x02013;<lpage>1912</lpage>
<pub-id pub-id-type="doi">10.1074/mcp.M116.058016</pub-id>
<?supplied-pmid 26984886?><pub-id pub-id-type="pmid">26984886</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>S.</given-names></name>, <name><surname>Shah</surname><given-names>P.</given-names></name>, <name><surname>Eshghi</surname><given-names>S.T.</given-names></name>, <name><surname>Yang</surname><given-names>W.</given-names></name>, <name><surname>Trikannad</surname><given-names>N.</given-names></name>, <name><surname>Yang</surname><given-names>S.</given-names></name></person-group>
<etal/> (<year>2016</year>) <article-title>Comprehensive analysis of protein glycosylation by solid-phase extraction of N-linked glycans and glycosite-containing peptides</article-title>. <source>Nat. Biotechnol.</source>
<volume>34</volume>, <fpage>84</fpage>&#x02013;<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.3403</pub-id>
<?supplied-pmid 26571101?><pub-id pub-id-type="pmid">26571101</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thaysen-Andersen</surname><given-names>M.</given-names></name>, <name><surname>Packer</surname><given-names>N.H.</given-names></name> and <name><surname>Schulz</surname><given-names>B.L.</given-names></name></person-group> (<year>2016</year>) <article-title>Maturing glycoproteomics technologies provide unique structural insights into the N-glycoproteome and its regulation in health and disease</article-title>. <source>Mol. Cell. Proteomics</source>
<volume>15</volume>, <fpage>1773</fpage>&#x02013;<lpage>1790</lpage>
<pub-id pub-id-type="doi">10.1074/mcp.O115.057638</pub-id>
<?supplied-pmid 26929216?><pub-id pub-id-type="pmid">26929216</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>Y.</given-names></name> and <name><surname>Cipollo</surname><given-names>J.F.</given-names></name></person-group> (<year>2011</year>) <article-title>An unbiased approach for analysis of protein glycosylation and application to influenza vaccine hemagglutinin</article-title>. <source>Anal. Biochem.</source>
<volume>415</volume>, <fpage>67</fpage>&#x02013;<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1016/j.ab.2011.04.018</pub-id>
<?supplied-pmid 21545787?><pub-id pub-id-type="pmid">21545787</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaraman</surname><given-names>A.</given-names></name>, <name><surname>Koh</surname><given-names>X.</given-names></name>, <name><surname>Li</surname><given-names>J.</given-names></name>, <name><surname>Raman</surname><given-names>R.</given-names></name>, <name><surname>Viswanathan</surname><given-names>K.</given-names></name>, <name><surname>Shriver</surname><given-names>Z.</given-names></name></person-group>
<etal/> (<year>2012</year>) <article-title>Glycosylation at Asn91 of H1N1 haemagglutinin affects binding to glycan receptors</article-title>. <source>Biochem. J.</source>
<volume>444</volume>, <fpage>429</fpage>&#x02013;<lpage>435</lpage>
<pub-id pub-id-type="doi">10.1042/BJ20112101</pub-id>
<?supplied-pmid 22642577?><pub-id pub-id-type="pmid">22642577</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>Y.</given-names></name>, <name><surname>Rininger</surname><given-names>J.A.</given-names></name>, <name><surname>Jarvis</surname><given-names>D.L.</given-names></name>, <name><surname>Jing</surname><given-names>X.</given-names></name>, <name><surname>Ye</surname><given-names>Z.</given-names></name>, <name><surname>Aumiller</surname><given-names>J.J.</given-names></name></person-group>
<etal/> (<year>2013</year>) <article-title>Comparative glycomics analysis of influenza Hemagglutinin (H5N1) produced in vaccine relevant cell platforms</article-title>. <source>J. Proteome Res.</source>
<volume>12</volume>, <fpage>3707</fpage>&#x02013;<lpage>3720</lpage>
<pub-id pub-id-type="doi">10.1021/pr400329k</pub-id>
<?supplied-pmid 23848607?><pub-id pub-id-type="pmid">23848607</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name>, <name><surname>Zhong</surname><given-names>Y.</given-names></name>, <name><surname>Su</surname><given-names>R.</given-names></name>, <name><surname>Qi</surname><given-names>H.</given-names></name>, <name><surname>Deng</surname><given-names>W.</given-names></name>, <name><surname>Sun</surname><given-names>Y.</given-names></name></person-group>
<etal/> (<year>2017</year>) <article-title>N-glycan profiles in H9N2 avian influenza viruses from chicken eggs and human embryonic lung fibroblast cells</article-title>. <source>J. Virol. Methods</source>
<volume>249</volume>, <fpage>10</fpage>&#x02013;<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1016/j.jviromet.2017.08.002</pub-id>
<?supplied-pmid 28797655?><pub-id pub-id-type="pmid">28797655</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>E.</given-names></name>, <name><surname>Cain</surname><given-names>J.</given-names></name>, <name><surname>Crossett</surname><given-names>B.</given-names></name> and <name><surname>Kayser</surname><given-names>V.</given-names></name></person-group> (<year>2018</year>) <article-title>Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry</article-title>. <source>Hum. Vaccin. Immunother.</source>
<volume>14</volume>, <fpage>508</fpage>&#x02013;<lpage>517</lpage>
<pub-id pub-id-type="doi">10.1080/21645515.2017.1377871</pub-id>
<?supplied-pmid 29048990?><pub-id pub-id-type="pmid">29048990</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>L.</given-names></name>, <name><surname>Diedrich</surname><given-names>J.K</given-names></name>, <name><surname>Ma</surname><given-names>Y.</given-names></name>, <name><surname>Wang</surname><given-names>N.</given-names></name>, <name><surname>Pauthner</surname><given-names>M.</given-names></name>, <name><surname>Park</surname><given-names>S.-K.R.</given-names></name></person-group>
<etal/> (<year>2018</year>) <article-title>Global site-specific analysis of glycoprotein N-glycan processing</article-title>. <source>Nat. Protoc.</source>
<volume>13</volume>, <fpage>1196</fpage>&#x02013;<lpage>1212</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2018.024</pub-id>
<?supplied-pmid 29725121?><pub-id pub-id-type="pmid">29725121</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skehel</surname><given-names>J.J.</given-names></name>, <name><surname>Stevens</surname><given-names>D.J.</given-names></name>, <name><surname>Daniels</surname><given-names>R.S.</given-names></name>, <name><surname>Douglas</surname><given-names>A.R.</given-names></name>, <name><surname>Knossow</surname><given-names>M.</given-names></name>, <name><surname>Wilson</surname><given-names>I.A.</given-names></name></person-group>
<etal/> (<year>1984</year>) <article-title>A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>81</volume>, <fpage>1779</fpage>&#x02013;<lpage>1783</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.81.6.1779</pub-id>
<?supplied-pmid 6584912?><pub-id pub-id-type="pmid">6584912</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCullers</surname><given-names>J.A.</given-names></name></person-group> (<year>2014</year>) <article-title>The co-pathogenesis of influenza viruses with bacteria in the lung</article-title>. <source>Nat. Rev. Microbiol.</source>
<volume>12</volume>, <fpage>252</fpage>&#x02013;<lpage>262</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro3231</pub-id>
<?supplied-pmid 24590244?><pub-id pub-id-type="pmid">24590244</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>P.</given-names></name>, <name><surname>Jang</surname><given-names>Y.H.</given-names></name>, <name><surname>Kwon</surname><given-names>S.B.</given-names></name>, <name><surname>Lee</surname><given-names>C.M.</given-names></name>, <name><surname>Han</surname><given-names>G.</given-names></name> and <name><surname>Seong</surname><given-names>B.L.</given-names></name></person-group> (<year>2018</year>) <article-title>Glycosylation of hemagglutinin of influenza A virus as a signature for ecological spillover and adaptation among influenza reservoirs</article-title>. <source>Viruses</source>
<volume>10</volume>, <fpage>183</fpage>
<pub-id pub-id-type="doi">10.3390/v10040183</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>S.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name> and <name><surname>Hartshorn</surname><given-names>K.L.</given-names></name></person-group> (<year>2015</year>) <article-title>The amazing innate immune response to influenza A virus infection</article-title>. <source>Innate Immun.</source>
<volume>21</volume>, <fpage>73</fpage>&#x02013;<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1177/1753425913508992</pub-id>
<?supplied-pmid 24217220?><pub-id pub-id-type="pmid">24217220</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gottschalk</surname><given-names>A.</given-names></name>, <name><surname>Belyavin</surname><given-names>G.</given-names></name> and <name><surname>Biddle</surname><given-names>F.</given-names></name></person-group> (<year>1972</year>) <article-title>Glycoproteins as influenza virus hemagglutinin inhibitors and as cellular receptors</article-title>. In <source>Glycoproteins. Their Composition, Structure and Function</source> (<person-group person-group-type="editor"><name><surname>Gottschalk</surname><given-names>A.</given-names></name></person-group>, ed.), pp. <fpage>1082</fpage>&#x02013;<lpage>1096</lpage>, <publisher-name>Elsevier Science Publishing</publisher-name>, <publisher-loc>New York, NY, U.S.A.</publisher-loc></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname><given-names>E.M.</given-names></name>, <name><surname>Hartley</surname><given-names>C.A.</given-names></name> and <name><surname>Jackson</surname><given-names>D.C.</given-names></name></person-group> (<year>1990</year>) <article-title>Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>87</volume>, <fpage>4485</fpage>&#x02013;<lpage>4489</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.87.12.4485</pub-id><pub-id pub-id-type="pmid">2162043</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartley</surname><given-names>C.A.</given-names></name>, <name><surname>Jackson</surname><given-names>D.C.</given-names></name> and <name><surname>Anders</surname><given-names>E.M.</given-names></name></person-group> (<year>1992</year>) <article-title>Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: Identification of bovine sera beta inhibitors as conglutinin</article-title>. <source>J. Virol.</source>
<volume>66</volume>, <fpage>4358</fpage>&#x02013;<lpage>4363</lpage>
<?supplied-pmid 1602549?><pub-id pub-id-type="pmid">1602549</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drickamer</surname><given-names>K.</given-names></name></person-group> (<year>1999</year>) <article-title>C-type lectin-like domains</article-title>. <source>Curr. Opin. Struct. Biol.</source>
<volume>9</volume>, <fpage>585</fpage>&#x02013;<lpage>590</lpage>
<pub-id pub-id-type="doi">10.1016/S0959-440X(99)00009-3</pub-id>
<?supplied-pmid 10508765?><pub-id pub-id-type="pmid">10508765</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tecle</surname><given-names>T.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name>, <name><surname>Crouch</surname><given-names>E.C.</given-names></name> and <name><surname>Hartshorn</surname><given-names>K.L.</given-names></name></person-group> (<year>2007</year>) <article-title>Inhibition of influenza viral neuraminidase activity by collectins</article-title>. <source>Arch. Virol.</source>
<volume>152</volume>, <fpage>1731</fpage>&#x02013;<lpage>1742</lpage>
<pub-id pub-id-type="doi">10.1007/s00705-007-0983-4</pub-id>
<?supplied-pmid 17514488?><pub-id pub-id-type="pmid">17514488</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veldhuizen</surname><given-names>E.J.A.</given-names></name>, <name><surname>van Eijk</surname><given-names>M.</given-names></name> and <name><surname>Haagsman</surname><given-names>H.P.</given-names></name></person-group> (<year>2011</year>) <article-title>The carbohydrate recognition domain of collectins</article-title>. <source>FEBS J.</source>
<volume>278</volume>, <fpage>3930</fpage>&#x02013;<lpage>3941</lpage>
<pub-id pub-id-type="doi">10.1111/j.1742-4658.2011.08206.x</pub-id>
<?supplied-pmid 21651725?><pub-id pub-id-type="pmid">21651725</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drickamer</surname><given-names>K.</given-names></name></person-group> (<year>1988</year>) <article-title>Two distinct classes of carbohydrate-recognition domains in animal lectins</article-title>. <source>J. Biologic. Chem.</source>
<volume>263</volume>, <fpage>9557</fpage>&#x02013;<lpage>9560</lpage></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>P.H.</given-names></name>, <name><surname>Weilguny</surname><given-names>D.</given-names></name>, <name><surname>Matthiesen</surname><given-names>F.</given-names></name>, <name><surname>McGuire</surname><given-names>K.A.</given-names></name>, <name><surname>Shi</surname><given-names>L.</given-names></name> and <name><surname>Hojrup</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>) <article-title>Characterization of the oligomer structure of recombinant human mannan-binding lectin</article-title>. <source>J. Biol. Chem.</source>
<volume>280</volume>, <fpage>11043</fpage>&#x02013;<lpage>11051</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M412472200</pub-id>
<?supplied-pmid 15653690?><pub-id pub-id-type="pmid">15653690</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akiyama</surname><given-names>J.</given-names></name>, <name><surname>Hoffman</surname><given-names>A.</given-names></name>, <name><surname>Brown</surname><given-names>C.</given-names></name>, <name><surname>Allen</surname><given-names>L.</given-names></name>, <name><surname>Edmondson</surname><given-names>J.</given-names></name>, <name><surname>Poulain</surname><given-names>F.</given-names></name></person-group>
<etal/> (<year>2002</year>) <article-title>Tissue distribution of surfactant proteins A and D in the mouse</article-title>. <source>J. Histochem. Cytochem.</source>
<volume>50</volume>, <fpage>993</fpage>&#x02013;<lpage>996</lpage>
<pub-id pub-id-type="doi">10.1177/002215540205000713</pub-id>
<?supplied-pmid 12070278?><pub-id pub-id-type="pmid">12070278</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>M.</given-names></name>, <name><surname>Evans</surname><given-names>D.J.</given-names></name>, <name><surname>Hawgood</surname><given-names>S.</given-names></name>, <name><surname>Anders</surname><given-names>E.M.</given-names></name>, <name><surname>Sack</surname><given-names>R.A.</given-names></name> and <name><surname>Fleiszig</surname><given-names>S.M.J.</given-names></name></person-group> (<year>2005</year>) <article-title>Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Infect. Immun.</source>
<volume>74</volume>, <fpage>2147</fpage>&#x02013;<lpage>2156</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.73.4.2147-2156.2005</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishore</surname><given-names>U.</given-names></name>, <name><surname>Greenhough</surname><given-names>T.J.</given-names></name>, <name><surname>Waters</surname><given-names>P.</given-names></name>, <name><surname>Shrive</surname><given-names>A.K.</given-names></name>, <name><surname>Chai</surname><given-names>R.</given-names></name>, <name><surname>Kamran</surname><given-names>M.F.</given-names></name></person-group>
<etal/> (<year>2006</year>) <article-title>Surfactant proteins SP-A and SP-D: Structure, function and receptors</article-title>. <source>Mol. Immunol.</source>
<volume>43</volume>, <fpage>1293</fpage>&#x02013;<lpage>1315</lpage>
<pub-id pub-id-type="doi">10.1016/j.molimm.2005.08.004</pub-id>
<?supplied-pmid 16213021?><pub-id pub-id-type="pmid">16213021</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensenius</surname><given-names>H.</given-names></name>, <name><surname>Klein</surname><given-names>D.C.</given-names></name>, <name><surname>van Hecke</surname><given-names>M.</given-names></name>, <name><surname>Oosterkamp</surname><given-names>T.H.</given-names></name>, <name><surname>Schmidt</surname><given-names>T.</given-names></name> and <name><surname>Jensenius</surname><given-names>J.C.</given-names></name></person-group> (<year>2009</year>) <article-title>Mannan-binding lectin: Structure, oligomerization, and flexibility studied by atomic force microscopy</article-title>. <source>J. Mol. Biol.</source>
<volume>391</volume>, <fpage>246</fpage>&#x02013;<lpage>259</lpage>
<pub-id pub-id-type="doi">10.1016/j.jmb.2009.05.083</pub-id>
<?supplied-pmid 19501100?><pub-id pub-id-type="pmid">19501100</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madsen</surname><given-names>H.O.</given-names></name>, <name><surname>Garred</surname><given-names>P.</given-names></name>, <name><surname>Kurtzhals</surname><given-names>J.A.</given-names></name>, <name><surname>Lamm</surname><given-names>L.U.</given-names></name>, <name><surname>Ryder</surname><given-names>L.P.</given-names></name>, <name><surname>Thiel</surname><given-names>S.</given-names></name></person-group>
<etal/> (<year>1994</year>) <article-title>A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein</article-title>. <source>Immunogenetics</source>
<volume>40</volume>, <fpage>37</fpage>&#x02013;<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1007/BF00163962</pub-id>
<?supplied-pmid 8206524?><pub-id pub-id-type="pmid">8206524</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madsen</surname><given-names>H.O.</given-names></name>, <name><surname>Satz</surname><given-names>M.L.</given-names></name>, <name><surname>Hogh</surname><given-names>B.</given-names></name>, <name><surname>Svejgaard</surname><given-names>A.</given-names></name> and <name><surname>Garred</surname><given-names>P.</given-names></name></person-group> (<year>1998</year>) <article-title>Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America</article-title>. <source>J. Immunol.</source>
<volume>161</volume>, <fpage>3169</fpage>&#x02013;<lpage>3175</lpage>
<?supplied-pmid 9743385?><pub-id pub-id-type="pmid">9743385</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipscombe</surname><given-names>R.J.</given-names></name>, <name><surname>Sumiya</surname><given-names>M.</given-names></name>, <name><surname>Summerfield</surname><given-names>J.A.</given-names></name> and <name><surname>Turner</surname><given-names>M.W.</given-names></name></person-group> (<year>1995</year>) <article-title>Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype</article-title>. <source>Immunology</source>
<volume>85</volume>, <fpage>660</fpage>&#x02013;<lpage>667</lpage><pub-id pub-id-type="pmid">7558163</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalmers</surname><given-names>J.D.</given-names></name>, <name><surname>McHugh</surname><given-names>B.J.</given-names></name>, <name><surname>Doherty</surname><given-names>C.</given-names></name>, <name><surname>Smith</surname><given-names>M.P.</given-names></name>, <name><surname>Govan</surname><given-names>J.R.</given-names></name>, <name><surname>Kilpatrick</surname><given-names>D.C.</given-names></name></person-group>
<etal/> (<year>2013</year>) <article-title>Mannose-binding lectin deficiency and disease severity in non-cystic fibrosis bronchiectasis: a prospective study</article-title>. <source>Lancet Respir. Med.</source>
<volume>1</volume>, <fpage>224</fpage>&#x02013;<lpage>232</lpage>
<pub-id pub-id-type="doi">10.1016/S2213-2600(13)70001-8</pub-id>
<?supplied-pmid 24429128?><pub-id pub-id-type="pmid">24429128</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillaire</surname><given-names>M.L.</given-names></name>, <name><surname>van Eijk</surname><given-names>M.</given-names></name>, <name><surname>Vogelzang-van Trierum</surname><given-names>S.E.</given-names></name>, <name><surname>Nieuwkoop</surname><given-names>N.J.</given-names></name>, <name><surname>van Riel</surname><given-names>D.</given-names></name>, <name><surname>Fouchier</surname><given-names>R.A.</given-names></name></person-group>
<etal/> (<year>2015</year>) <article-title>Assessment of the antiviral properties of recombinant surfactant protein D against B viruses in vitro</article-title>. <source>Virus Res.</source>
<volume>2</volume>, <fpage>43</fpage>&#x02013;<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1016/j.virusres.2014.08.019</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W.</given-names></name> and <name><surname>Metcalf</surname><given-names>J.P.</given-names></name></person-group> (<year>2014</year>) <article-title>Editorial: mannose-binding lectin in fighting influenza: promise or peril?</article-title>
<source>J. Leuk. Biol.</source>
<volume>95</volume>, <fpage>702</fpage>&#x02013;<lpage>704</lpage>
<pub-id pub-id-type="doi">10.1189/jlb.0114003</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reading</surname><given-names>P.C.</given-names></name>, <name><surname>Morey</surname><given-names>L.S.</given-names></name>, <name><surname>Crouch</surname><given-names>E.C.</given-names></name> and <name><surname>Anders</surname><given-names>E.M.</given-names></name></person-group> (<year>1997</year>) <article-title>Collectin-mediated antiviral host defense in the lung: evidence from influenza virus infection in mice</article-title>. <source>J. Virol.</source>
<volume>71</volume>, <fpage>8204</fpage>&#x02013;<lpage>8212</lpage>
<?supplied-pmid 9343171?><pub-id pub-id-type="pmid">9343171</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingma</surname><given-names>P.S.</given-names></name>, <name><surname>Zhang</surname><given-names>L.</given-names></name>, <name><surname>Ikegami</surname><given-names>M.</given-names></name>, <name><surname>Hartshorn</surname><given-names>K.</given-names></name>, <name><surname>McCormack</surname><given-names>F.X.</given-names></name> and <name><surname>Whitsett</surname><given-names>J.A.</given-names></name></person-group> (<year>2006</year>) <article-title>Correction of pulmonary abnormalities in Sftpd-/- mice requires the collagenous domain of surfactant protein D</article-title>. <source>J. Biol. Chem.</source>
<volume>281</volume>, <fpage>24496</fpage>&#x02013;<lpage>24505</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M600651200</pub-id>
<?supplied-pmid 16787926?><pub-id pub-id-type="pmid">16787926</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigerust</surname><given-names>D.J.</given-names></name>, <name><surname>Ulett</surname><given-names>K.B.</given-names></name>, <name><surname>Boyd</surname><given-names>K.L.</given-names></name>, <name><surname>Madsen</surname><given-names>J.</given-names></name>, <name><surname>Hawgood</surname><given-names>S.</given-names></name> and <name><surname>McCullers</surname><given-names>J.A.</given-names></name></person-group> (<year>2007</year>) <article-title>N-linked glycosylation attenuates H3N2 influenza viruses</article-title>. <source>J. Virol.</source>
<volume>81</volume>, <fpage>8593</fpage>&#x02013;<lpage>8600</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.00769-07</pub-id>
<?supplied-pmid 17553891?><pub-id pub-id-type="pmid">17553891</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tate</surname><given-names>M.D</given-names></name>, <name><surname>Job</surname><given-names>E.R.</given-names></name>, <name><surname>Brooks</surname><given-names>A.G.</given-names></name> and <name><surname>Reading</surname><given-names>P.C.</given-names></name></person-group> (<year>2011</year>) <article-title>Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice</article-title>. <source>Virology</source>
<volume>413</volume>, <fpage>84</fpage>&#x02013;<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1016/j.virol.2011.01.036</pub-id><pub-id pub-id-type="pmid">21353279</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanzeck</surname><given-names>K.</given-names></name>, <name><surname>Boyd</surname><given-names>K.L.</given-names></name> and <name><surname>McCullers</surname><given-names>J.A.</given-names></name></person-group> (<year>2011</year>) <article-title>Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice</article-title>. <source>Am. J. Respir. Crit. Care Med.</source>
<volume>183</volume>, <fpage>767</fpage>&#x02013;<lpage>773</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.201007-1184OC</pub-id>
<?supplied-pmid 20935106?><pub-id pub-id-type="pmid">20935106</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Job</surname><given-names>E.R.</given-names></name>, <name><surname>Deng</surname><given-names>Y.M.</given-names></name>, <name><surname>Tate</surname><given-names>M.D.</given-names></name>, <name><surname>Bottazzi</surname><given-names>B.</given-names></name>, <name><surname>Crouch</surname><given-names>E.C.</given-names></name>, <name><surname>Dean</surname><given-names>M.M.</given-names></name></person-group>
<etal/> (<year>2010</year>) <article-title>Pandemic H1N1 influenza a viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies</article-title>. <source>J. Immunol.</source>
<volume>185</volume>, <fpage>4284</fpage>&#x02013;<lpage>4291</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1001613</pub-id>
<?supplied-pmid 20817882?><pub-id pub-id-type="pmid">20817882</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi.</surname><given-names>L.</given-names></name>, <name><surname>Kash</surname><given-names>J.C.</given-names></name>, <name><surname>Dugan</surname><given-names>V.G.</given-names></name>, <name><surname>Jagger</surname><given-names>B.W.</given-names></name>, <name><surname>Lau</surname><given-names>Y.F.</given-names></name>, <name><surname>Sheng</surname><given-names>Z.M.</given-names></name></person-group>
<etal/> (<year>2011</year>) <article-title>The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding</article-title>. <source>Virology</source>
<volume>412</volume>, <fpage>426</fpage>&#x02013;<lpage>434</lpage>
<pub-id pub-id-type="doi">10.1016/j.virol.2011.01.029</pub-id><pub-id pub-id-type="pmid">21334038</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokunaga</surname><given-names>H.</given-names></name>, <name><surname>Ushirogawa</surname><given-names>H.</given-names></name> and <name><surname>Ohuchi</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>) <article-title>The pandemic (H1N1) 2009 influenza virus is resistant to mannose-binding lectin</article-title>. <source>Virol. J.</source>
<volume>8</volume>, <fpage>50</fpage>
<pub-id pub-id-type="doi">10.1186/1743-422X-8-50</pub-id>
<?supplied-pmid 21294904?><pub-id pub-id-type="pmid">21294904</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>X.</given-names></name>, <name><surname>Zengel</surname><given-names>J.R.</given-names></name>, <name><surname>Xu</surname><given-names>Q.</given-names></name> and <name><surname>Jin</surname><given-names>H.</given-names></name></person-group> (<year>2012</year>) <article-title>Surface glycoproteins of influenza A H3N2 virus modulate virus replication in the respiratory tract of ferrets</article-title>. <source>Virology</source>
<volume>432</volume>, <fpage>91</fpage>&#x02013;<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1016/j.virol.2012.06.002</pub-id><pub-id pub-id-type="pmid">22743127</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Job</surname><given-names>E.R.</given-names></name>, <name><surname>Pizzolla</surname><given-names>A.</given-names></name>, <name><surname>Nebl</surname><given-names>T.</given-names></name>, <name><surname>Short</surname><given-names>K.R.</given-names></name>, <name><surname>Deng</surname><given-names>Y.M.</given-names></name>, <name><surname>Carolan</surname><given-names>L.</given-names></name></person-group>
<etal/> (<year>2016</year>) <article-title>Neutralizing inhibitors in the airways of na&#x000ef;ve ferrets do not play a major role in modulating the virulence of H3 subtype influenza A viruses</article-title>. <source>Virology</source>
<volume>494</volume>, <fpage>143</fpage>&#x02013;<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1016/j.virol.2016.01.024</pub-id><pub-id pub-id-type="pmid">27110707</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L.</given-names></name>, <name><surname>Shang</surname><given-names>S.</given-names></name>, <name><surname>Tao</surname><given-names>R.</given-names></name>, <name><surname>Wang</surname><given-names>C.</given-names></name>, <name><surname>Zhang</surname><given-names>L.</given-names></name>, <name><surname>Peng</surname><given-names>H.</given-names></name></person-group>
<etal/> (<year>2017</year>) <article-title>High doses of recombinant mannan-binding lectin inhibit the binding of influenza A(H1N1)pdm09 virus with cells expressing DC-SIGN</article-title>. <source>APMIS</source>
<volume>125</volume>, <fpage>655</fpage>&#x02013;<lpage>664</lpage>
<pub-id pub-id-type="doi">10.1111/apm.12695</pub-id>
<?supplied-pmid 28493491?><pub-id pub-id-type="pmid">28493491</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartshorn</surname><given-names>K.L.</given-names></name>, <name><surname>Webby</surname><given-names>R.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name>, <name><surname>Tecle</surname><given-names>T.</given-names></name>, <name><surname>Pan</surname><given-names>C.</given-names></name>, <name><surname>Boucher</surname><given-names>S.</given-names></name></person-group>
<etal/> (<year>2008</year>) <article-title>Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D</article-title>. <source>Respir. Res.</source>
<volume>9</volume>, <fpage>65</fpage>
<pub-id pub-id-type="doi">10.1186/1465-9921-9-65</pub-id><pub-id pub-id-type="pmid">18811961</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kongchanagul</surname><given-names>A.</given-names></name>, <name><surname>Suptawiwat</surname><given-names>O.</given-names></name>, <name><surname>Boonarkart</surname><given-names>C.</given-names></name>, <name><surname>Kitphati</surname><given-names>R.</given-names></name>, <name><surname>Puthavathana</surname><given-names>P.</given-names></name>, <name><surname>Uiprasertkul</surname><given-names>M.</given-names></name></person-group>
<etal/> (<year>2011</year>) <article-title>Decreased expression of surfactant protein D mRNA in human lungs in fatal cases of H5N1 avian influenza</article-title>. <source>J. Med. Virol.</source>
<volume>83</volume>, <fpage>1410</fpage>&#x02013;<lpage>1417</lpage>
<pub-id pub-id-type="doi">10.1002/jmv.22105</pub-id>
<?supplied-pmid 21678446?><pub-id pub-id-type="pmid">21678446</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panaampon</surname><given-names>J.</given-names></name>, <name><surname>Ngaosuwankul</surname><given-names>N.</given-names></name>, <name><surname>Suptawiwat</surname><given-names>O.</given-names></name>, <name><surname>Noisumdaeng</surname><given-names>P.</given-names></name>, <name><surname>Sangsiriwut</surname><given-names>K.</given-names></name>, <name><surname>Siridechadilok</surname><given-names>B.</given-names></name></person-group>
<etal/> (<year>2012</year>) <article-title>A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors</article-title>. <source>PLoS One</source>
<volume>7</volume>, <fpage>e36318</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0036318</pub-id>
<?supplied-pmid 22563489?><pub-id pub-id-type="pmid">22563489</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>J.</given-names></name>, <name><surname>Cao</surname><given-names>Y.</given-names></name>, <name><surname>Qin</surname><given-names>K.</given-names></name>, <name><surname>Zhao</surname><given-names>X.</given-names></name>, <name><surname>Wang</surname><given-names>D.</given-names></name> and <name><surname>Li</surname><given-names>Z.</given-names></name></person-group> (<year>2015</year>) <article-title>Limited effect of recombinant human mannose-binding lectin on the infection of novel influenza A (H7N9) virus in vitro</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>458</volume>, <fpage>77</fpage>&#x02013;<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2015.01.070</pub-id>
<?supplied-pmid 25634695?><pub-id pub-id-type="pmid">25634695</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>W.C.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name>, <name><surname>Moyo</surname><given-names>P.</given-names></name>, <name><surname>McClear</surname><given-names>S.</given-names></name>, <name><surname>Thiel</surname><given-names>S.</given-names></name>, <name><surname>Hartshorn</surname><given-names>K.L.</given-names></name></person-group>
<etal/> (<year>2010</year>) <article-title>Lack of pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection</article-title>. <source>BMC Immunol.</source>
<volume>11</volume>, <fpage>6A</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2172-11-64</pub-id><pub-id pub-id-type="pmid">20163714</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tate</surname><given-names>M.D.</given-names></name>, <name><surname>Brooks</surname><given-names>A.G.</given-names></name> and <name><surname>Reading</surname><given-names>P.C.</given-names></name></person-group> (<year>2011</year>) <article-title>Inhibition of lectin-mediated innate host defenses in vivo modulates disease severity during influenza virus infection</article-title>. <source>Immunol. Cell Biol.</source>
<volume>89</volume>, <fpage>482</fpage>&#x02013;<lpage>491</lpage>
<pub-id pub-id-type="doi">10.1038/icb.2010.113</pub-id>
<?supplied-pmid 20938455?><pub-id pub-id-type="pmid">20938455</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X.</given-names></name>, <name><surname>Jayaraman</surname><given-names>A.</given-names></name>, <name><surname>Maniprasad</surname><given-names>P.</given-names></name>, <name><surname>Raman</surname><given-names>R.</given-names></name>, <name><surname>Houser</surname><given-names>K.V.</given-names></name>, <name><surname>Pappas</surname><given-names>C.</given-names></name></person-group>
<etal/> (<year>2013</year>) <article-title>N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses</article-title>. <source>J. Virol.</source>
<volume>87</volume>, <fpage>8756</fpage>&#x02013;<lpage>8766</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.00593-13</pub-id>
<?supplied-pmid 23740978?><pub-id pub-id-type="pmid">23740978</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeVine</surname><given-names>A.M.</given-names></name>, <name><surname>Whitsett</surname><given-names>J.A.</given-names></name>, <name><surname>Hartshorn</surname><given-names>K.L.</given-names></name>, <name><surname>Crouch</surname><given-names>E.C.</given-names></name> and <name><surname>Korfhagen</surname><given-names>T.R.</given-names></name></person-group> (<year>2001</year>) <article-title>Surfactant protein D enhances clearance of influenza A virus from the lung <italic>in vivo</italic></article-title>. <source>J. Immunol.</source>
<volume>167</volume>, <fpage>5868</fpage>&#x02013;<lpage>5873</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.167.10.5868</pub-id>
<?supplied-pmid 11698462?><pub-id pub-id-type="pmid">11698462</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawgood</surname><given-names>S.</given-names></name>, <name><surname>Brown</surname><given-names>C.</given-names></name>, <name><surname>Edmondson</surname><given-names>J.</given-names></name>, <name><surname>Stumbaugh</surname><given-names>A.</given-names></name>, <name><surname>Allen</surname><given-names>L.</given-names></name>, <name><surname>Goerke</surname><given-names>J.</given-names></name></person-group>
<etal/> (<year>2004</year>) <article-title>Pulmanary collectins modulate strain-specific influenza A virus infection and host responses</article-title>. <source>J. Virol.</source>
<volume>78</volume>, <fpage>8565</fpage>&#x02013;<lpage>8672</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.78.16.8565-8572.2004</pub-id>
<?supplied-pmid 15280465?><pub-id pub-id-type="pmid">15280465</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belser</surname><given-names>J.A.</given-names></name>, <name><surname>Eckert</surname><given-names>A.M.</given-names></name>, <name><surname>Tumpey</surname><given-names>T.M.</given-names></name> and <name><surname>Maines</surname><given-names>T.R.</given-names></name></person-group> (<year>2016</year>) <article-title>Complexities in ferret influenza virus pathogenesis and transmission models</article-title>. <source>Microbiol. Mol. Biol. Rev.</source>
<volume>80</volume>, <fpage>733</fpage>&#x02013;<lpage>744</lpage>
<pub-id pub-id-type="doi">10.1128/MMBR.00022-16</pub-id>
<?supplied-pmid 27412880?><pub-id pub-id-type="pmid">27412880</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>M.T.</given-names></name>, <name><surname>Tu</surname><given-names>W.</given-names></name> and <name><surname>Han</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>) <article-title>Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection</article-title>. <source>J. Infect. Dis.</source>
<volume>205</volume>, <fpage>44</fpage>&#x02013;<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jir691</pub-id>
<?supplied-pmid 22080095?><pub-id pub-id-type="pmid">22080095</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>Y.</given-names></name>, <name><surname>Takahashi</surname><given-names>H.</given-names></name>, <name><surname>Kuroki</surname><given-names>Y.</given-names></name>, <name><surname>Akino</surname><given-names>T.</given-names></name> and <name><surname>Abe</surname><given-names>S.</given-names></name></person-group> (<year>1996</year>) <article-title>Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers</article-title>. <source>Chest</source>
<volume>109</volume>, <fpage>1006</fpage>&#x02013;<lpage>1009</lpage>
<pub-id pub-id-type="doi">10.1378/chest.109.4.1006</pub-id>
<?supplied-pmid 8635323?><pub-id pub-id-type="pmid">8635323</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reading</surname><given-names>P.C.</given-names></name>, <name><surname>Allison</surname><given-names>J.</given-names></name>, <name><surname>Crouch</surname><given-names>E.C.</given-names></name> and <name><surname>Anders</surname><given-names>E.M.</given-names></name></person-group> (<year>1998</year>) <article-title>Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose?</article-title>
<source>J. Virol.</source>
<volume>72</volume>, <fpage>6884</fpage>&#x02013;<lpage>6887</lpage>
<?supplied-pmid 9658139?><pub-id pub-id-type="pmid">9658139</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noah</surname><given-names>T.L.</given-names></name>, <name><surname>Murphy</surname><given-names>P.C.</given-names></name> and <name><surname>Alink</surname><given-names>J.J.</given-names></name></person-group> (<year>2003</year>) <article-title>Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis</article-title>. <source>Am. J. Respir. Crit. Care Med.</source>
<volume>168</volume>, <fpage>685</fpage>&#x02013;<lpage>691</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.200301-005OC</pub-id>
<?supplied-pmid 12829455?><pub-id pub-id-type="pmid">12829455</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sims</surname><given-names>M.W.</given-names></name>, <name><surname>Tal-Singer</surname><given-names>R.M.</given-names></name>, <name><surname>Kierstein</surname><given-names>S.</given-names></name>, <name><surname>Musani</surname><given-names>A.I.</given-names></name>, <name><surname>Beers</surname><given-names>M.F.</given-names></name>, <name><surname>Panettieri</surname><given-names>R.A.</given-names></name></person-group>
<etal/> (<year>2008</year>) <article-title>Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study</article-title>. <source>Respir. Res.</source>
<volume>9</volume>, <fpage>13</fpage>
<pub-id pub-id-type="doi">10.1186/1465-9921-9-13</pub-id>
<?supplied-pmid 18226251?><pub-id pub-id-type="pmid">18226251</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>L.</given-names></name>, <name><surname>Shang</surname><given-names>S.</given-names></name>, <name><surname>Zhang</surname><given-names>C.</given-names></name>, <name><surname>Tong</surname><given-names>M.</given-names></name> and <name><surname>Chen</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>) <article-title>Lower mannose-binding lectin contributes to deleterious H1N1 2009 infection in children</article-title>. <source>APMIS</source>
<volume>122</volume>, <fpage>136</fpage>&#x02013;<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1111/apm.12111</pub-id>
<?supplied-pmid 23755909?><pub-id pub-id-type="pmid">23755909</pub-id></mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartshorn</surname><given-names>K.L.</given-names></name>, <name><surname>Sastry</surname><given-names>K.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name>, <name><surname>Anders</surname><given-names>E.M.</given-names></name>, <name><surname>Super</surname><given-names>M.</given-names></name>, <name><surname>Ezekowitz</surname><given-names>R.A.</given-names></name></person-group>
<etal/> (<year>1993</year>) <article-title>Human mannose-binding protein functions as an opsonin for influenza A viruses</article-title>. <source>J. Clin. Invest.</source>
<volume>91</volume>, <fpage>1414</fpage>&#x02013;<lpage>1420</lpage>
<pub-id pub-id-type="doi">10.1172/JCI116345</pub-id>
<?supplied-pmid 7682571?><pub-id pub-id-type="pmid">7682571</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartshorn</surname><given-names>K.L.</given-names></name>, <name><surname>Crouch</surname><given-names>E.C.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name>, <name><surname>Eggleton</surname><given-names>P.</given-names></name>, <name><surname>Tauber</surname><given-names>A.I.</given-names></name>, <name><surname>Chang</surname><given-names>D.</given-names></name></person-group>
<etal/> (<year>1994</year>) <article-title>Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses</article-title>. <source>J. Clin. Invest.</source>
<volume>94</volume>, <fpage>311</fpage>&#x02013;<lpage>319</lpage>
<pub-id pub-id-type="doi">10.1172/JCI117323</pub-id>
<?supplied-pmid 8040272?><pub-id pub-id-type="pmid">8040272</pub-id></mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartshorn</surname><given-names>K.L.</given-names></name>, <name><surname>Reid</surname><given-names>K.B.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name>, <name><surname>Jensenius</surname><given-names>J.C.</given-names></name>, <name><surname>Morris</surname><given-names>S.M.</given-names></name>, <name><surname>Tauber</surname><given-names>A.I.</given-names></name></person-group>
<etal/> (<year>1996</year>) <article-title>Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies</article-title>. <source>Blood</source>
<volume>87</volume>, <fpage>3450</fpage>&#x02013;<lpage>3461</lpage>
<?supplied-pmid 8605364?><pub-id pub-id-type="pmid">8605364</pub-id></mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartshorn</surname><given-names>K.L.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name>, <name><surname>Shepherd</surname><given-names>V.</given-names></name>, <name><surname>Reid</surname><given-names>K.</given-names></name>, <name><surname>Jensenius</surname><given-names>J.G.</given-names></name> and <name><surname>Crouch</surname><given-names>E.C.</given-names></name></person-group> (<year>1997</year>) <article-title>Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins</article-title>. <source>Am. J. Physiol.</source>
<volume>273</volume>, <fpage>L1156</fpage>&#x02013;<lpage>L1166</lpage>
<?supplied-pmid 9435570?><pub-id pub-id-type="pmid">9435570</pub-id></mixed-citation></ref><ref id="B127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kase</surname><given-names>T.</given-names></name>, <name><surname>Suzuki</surname><given-names>Y.</given-names></name>, <name><surname>Kawai</surname><given-names>T.</given-names></name>, <name><surname>Sakamoto</surname><given-names>T.</given-names></name>, <name><surname>Ohtani</surname><given-names>K.</given-names></name>, <name><surname>Eda</surname><given-names>S.</given-names></name></person-group>
<etal/> (<year>1999</year>) <article-title>Human mannan-binding lectin inhibits the infection of influenza a virus without complement</article-title>. <source>Immunology</source>
<volume>97</volume>, <fpage>385</fpage>&#x02013;<lpage>392</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2567.1999.00781.x</pub-id><pub-id pub-id-type="pmid">10447758</pub-id></mixed-citation></ref><ref id="B128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardai</surname><given-names>S.</given-names></name>, <name><surname>Xiao</surname><given-names>Y.Q.</given-names></name>, <name><surname>Dickinson</surname><given-names>M.</given-names></name>, <name><surname>Nick</surname><given-names>J.A.</given-names></name>, <name><surname>Voelker</surname><given-names>D.R.</given-names></name>, <name><surname>Greene</surname><given-names>K.E.</given-names></name></person-group>
<etal/> (<year>2003</year>) <article-title>By binding SIRP or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation</article-title>. <source>Cell</source>
<volume>115</volume>, <fpage>13</fpage>&#x02013;<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(03)00758-X</pub-id>
<?supplied-pmid 14531999?><pub-id pub-id-type="pmid">14531999</pub-id></mixed-citation></ref><ref id="B129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>C.J.</given-names></name>, <name><surname>Atochina-Vasserman</surname><given-names>E.N.</given-names></name>, <name><surname>Abramova</surname><given-names>E.</given-names></name>, <name><surname>Foley</surname><given-names>J.</given-names></name>, <name><surname>Zaman</surname><given-names>A.</given-names></name>, <name><surname>Crouch</surname><given-names>E.</given-names></name></person-group>
<etal/> (<year>2008</year>) <article-title>S-nitrosylation of surfactant protein-D controls inflammatory function</article-title>. <source>PLoS Biol.</source>
<volume>6</volume>, <fpage>e266</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.0060266</pub-id>
<?supplied-pmid 19007302?><pub-id pub-id-type="pmid">19007302</pub-id></mixed-citation></ref><ref id="B130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>T.</given-names></name>, <name><surname>Matsushita</surname><given-names>M.</given-names></name> and <name><surname>Endo</surname><given-names>Y.</given-names></name></person-group> (<year>2004</year>) <article-title>The lectin-complement pathway&#x02014;its role in innate immunity and evolution</article-title>. <source>Immunol. Rev.</source>
<volume>198</volume>, <fpage>185</fpage>&#x02013;<lpage>202</lpage>
<pub-id pub-id-type="doi">10.1111/j.0105-2896.2004.0123.x</pub-id>
<?supplied-pmid 15199963?><pub-id pub-id-type="pmid">15199963</pub-id></mixed-citation></ref><ref id="B131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>M.</given-names></name>, <name><surname>Mori</surname><given-names>S.</given-names></name>, <name><surname>Shigeta</surname><given-names>S.</given-names></name> and <name><surname>Fujita</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>) <article-title>Role of MBL-associated serine protease (MASP) on activation of the lectin complement pathway</article-title>. <source>Adv. Exp. Med. Biol.</source>
<volume>598</volume>, <fpage>93</fpage>&#x02013;<lpage>104</lpage>
<pub-id pub-id-type="doi">10.1007/978-0-387-71767-8_8</pub-id><pub-id pub-id-type="pmid">17892207</pub-id></mixed-citation></ref><ref id="B132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kase</surname><given-names>T.</given-names></name>, <name><surname>Suzuki</surname><given-names>Y.</given-names></name>, <name><surname>Kawai</surname><given-names>T.</given-names></name>, <name><surname>Sakamoto</surname><given-names>T.</given-names></name>, <name><surname>Ohtani</surname><given-names>K.</given-names></name>, <name><surname>Eda</surname><given-names>S.</given-names></name></person-group>
<etal/> (<year>1999</year>) <article-title>Human mannan-binding lectin inhibits the infection of influenza A virus without complement</article-title>. <source>Immunology</source>
<volume>97</volume>, <fpage>385</fpage>&#x02013;<lpage>392</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2567.1999.00781.x</pub-id><pub-id pub-id-type="pmid">10447758</pub-id></mixed-citation></ref><ref id="B133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tate</surname><given-names>M.D.</given-names></name>, <name><surname>Brooks</surname><given-names>A.G.</given-names></name> and <name><surname>Reading</surname><given-names>P.C.</given-names></name></person-group> (<year>2011</year>) <article-title>Specific sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype influenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice</article-title>. <source>J. Immunol.</source>
<volume>187</volume>, <fpage>1884</fpage>&#x02013;<lpage>1894</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1100295</pub-id>
<?supplied-pmid 21768397?><pub-id pub-id-type="pmid">21768397</pub-id></mixed-citation></ref><ref id="B134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillaire</surname><given-names>M.L.</given-names></name>, <name><surname>van Eijk</surname><given-names>M.</given-names></name>, <name><surname>Nieuwkoop</surname><given-names>N.J.</given-names></name>, <name><surname>Vogelzang-van Trierum</surname><given-names>S.E.</given-names></name>, <name><surname>Foucher</surname><given-names>R.A.</given-names></name>, <name><surname>Osterhaus</surname><given-names>A.D.</given-names></name></person-group>
<etal/> (<year>2012</year>) <article-title>The number and position of N-linked glycosylation sites in the hemagglutinin determine differential recognition of seasonal and 2009 pandemic H1N1 influenza virus by porcine surfactant protein D</article-title>. <source>Virus Res.</source>
<volume>169</volume>, <fpage>301</fpage>&#x02013;<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1016/j.virusres.2012.08.003</pub-id>
<?supplied-pmid 22921759?><pub-id pub-id-type="pmid">22921759</pub-id></mixed-citation></ref><ref id="B135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goh</surname><given-names>B.C.</given-names></name>, <name><surname>Rynkiewicz</surname><given-names>M.J.</given-names></name>, <name><surname>Cafarella</surname><given-names>T.R.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name>, <name><surname>Hartshorn</surname><given-names>K.L.</given-names></name>, <name><surname>Allen</surname><given-names>K.</given-names></name></person-group>
<etal/> (<year>2013</year>) <article-title>Molecular mechanisms of inhibition of influenza by surfactant protein D revealed by large-scale molecular dynamics simulation</article-title>. <source>Biochemistry</source>
<volume>52</volume>, <fpage>8527</fpage>&#x02013;<lpage>8538</lpage>
<pub-id pub-id-type="doi">10.1021/bi4010683</pub-id><pub-id pub-id-type="pmid">24224757</pub-id></mixed-citation></ref><ref id="B136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolaidis</surname><given-names>N.M.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name>, <name><surname>Allen</surname><given-names>K.</given-names></name>, <name><surname>Tripathi</surname><given-names>S.</given-names></name>, <name><surname>Qi</surname><given-names>L.</given-names></name>, <name><surname>McDonald</surname><given-names>B.</given-names></name></person-group>
<etal/> (<year>2014</year>) <article-title>Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses</article-title>. <source>Am. J. Physiol. Lung Cell Mol. Physiol.</source>
<volume>306</volume>, <fpage>L1036</fpage>&#x02013;<lpage>1044</lpage>
<pub-id pub-id-type="doi">10.1152/ajplung.00035.2014</pub-id>
<?supplied-pmid 24705721?><pub-id pub-id-type="pmid">24705721</pub-id></mixed-citation></ref><ref id="B137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Londrigan</surname><given-names>S.L.</given-names></name>, <name><surname>Tate</surname><given-names>M.D.</given-names></name> and <name><surname>Brooks</surname><given-names>A.G.</given-names></name></person-group> (<year>2012</year>) <article-title>Cell-surface receptors on macrophages and dendritic cells for attachment and entry of influenza virus</article-title>. <source>J. Leukoc. Biol.</source>
<volume>92</volume>, <fpage>97</fpage>&#x02013;<lpage>106</lpage>
<pub-id pub-id-type="doi">10.1189/jlb.1011492</pub-id>
<?supplied-pmid 22124137?><pub-id pub-id-type="pmid">22124137</pub-id></mixed-citation></ref><ref id="B138"><label>138</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grayson</surname><given-names>M.H.</given-names></name> and <name><surname>Holtzman</surname><given-names>M.J</given-names></name></person-group> (<year>2007</year>) <article-title>Emerging role of dendritic cells in respiratory viral infections</article-title>. <source>J. Mol. Med.</source>
<volume>85</volume>, <fpage>1057</fpage>&#x02013;<lpage>1068</lpage>
<pub-id pub-id-type="doi">10.1007/s00109-007-0212-3</pub-id>
<?supplied-pmid 17891367?><pub-id pub-id-type="pmid">17891367</pub-id></mixed-citation></ref><ref id="B139"><label>139</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tate</surname><given-names>M.D.</given-names></name>, <name><surname>Pickett</surname><given-names>D.L.</given-names></name>, <name><surname>van Rooijen</surname><given-names>N.</given-names></name>, <name><surname>Brooks</surname><given-names>A.G.</given-names></name> and <name><surname>Reading</surname><given-names>P.C.</given-names></name></person-group> (<year>2010</year>) <article-title>Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice</article-title>. <source>J. Virol.</source>
<volume>84</volume>, <fpage>7569</fpage>&#x02013;<lpage>7580</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.00291-10</pub-id>
<?supplied-pmid 20504924?><pub-id pub-id-type="pmid">20504924</pub-id></mixed-citation></ref><ref id="B140"><label>140</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thitithanyanont</surname><given-names>A.</given-names></name>, <name><surname>Engering</surname><given-names>A.</given-names></name>, <name><surname>Ekchariyawat</surname><given-names>P.</given-names></name>, <name><surname>Wiboon-ut</surname><given-names>S.</given-names></name>, <name><surname>Limsalakpetch</surname><given-names>A.</given-names></name>, <name><surname>Yongvanitchit</surname><given-names>K.</given-names></name></person-group>
<etal/> (<year>2007</year>) <article-title>High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands</article-title>. <source>J. Immunol.</source>
<volume>179</volume>, <fpage>5220</fpage>&#x02013;<lpage>5227</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.179.8.5220</pub-id>
<?supplied-pmid 17911607?><pub-id pub-id-type="pmid">17911607</pub-id></mixed-citation></ref><ref id="B141"><label>141</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrone</surname><given-names>L.A.</given-names></name>, <name><surname>Plowden</surname><given-names>J.K.</given-names></name>, <name><surname>Garc&#x000ed;a-Sastre</surname><given-names>A.</given-names></name>, <name><surname>Katz</surname><given-names>J.M.</given-names></name> and <name><surname>Tumpey</surname><given-names>T.M.</given-names></name></person-group> (<year>2008</year>) <article-title>H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice</article-title>. <source>PLoS Pathog.</source>
<volume>4</volume>, <fpage>e1000115</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1000115</pub-id>
<?supplied-pmid 18670648?><pub-id pub-id-type="pmid">18670648</pub-id></mixed-citation></ref><ref id="B142"><label>142</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manicassamy</surname><given-names>B.</given-names></name>, <name><surname>Manicassamy</surname><given-names>S.</given-names></name>, <name><surname>Belicha-Villanueva</surname><given-names>A.</given-names></name>, <name><surname>Pisanelli</surname><given-names>G.</given-names></name>, <name><surname>Pulendran</surname><given-names>B.</given-names></name> and <name><surname>Garc&#x000ed;a-Sastre</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>) <article-title>Analysis of <bold>in vivo</bold> dynamics of influenza virus infection in mice using a GFP reporter virus</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>107</volume>, <fpage>11531</fpage>&#x02013;<lpage>11536</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0914994107</pub-id><pub-id pub-id-type="pmid">20534532</pub-id></mixed-citation></ref><ref id="B143"><label>143</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cline</surname><given-names>T.D.</given-names></name>, <name><surname>Karlsson</surname><given-names>E.A.</given-names></name>, <name><surname>Seufzer</surname><given-names>B.J.</given-names></name> and <name><surname>Schultz-Cherry</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>) <article-title>The hemagglutinin protein of highly pathogenic H5N1 influenza viruses overcomes an early block in the replication cycle to promote productive replication in macrophages</article-title>. <source>J. Virol.</source>
<volume>87</volume>, <fpage>1411</fpage>&#x02013;<lpage>1419</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.02682-12</pub-id>
<?supplied-pmid 23152519?><pub-id pub-id-type="pmid">23152519</pub-id></mixed-citation></ref><ref id="B144"><label>144</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cline</surname><given-names>T.D.</given-names></name>, <name><surname>Beck</surname><given-names>D.</given-names></name> and <name><surname>Bianchini</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>) <article-title>Influenza virus replication in macrophages: balancing protection and pathogenesis</article-title>. <source>J. Gen. Virol.</source>
<volume>98</volume>, <fpage>2401</fpage>&#x02013;<lpage>2412</lpage>
<pub-id pub-id-type="doi">10.1099/jgv.0.000922</pub-id>
<?supplied-pmid 28884667?><pub-id pub-id-type="pmid">28884667</pub-id></mixed-citation></ref><ref id="B145"><label>145</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mummidi</surname><given-names>S.</given-names></name>, <name><surname>Catano</surname><given-names>G.</given-names></name>, <name><surname>Lam</surname><given-names>L.</given-names></name>, <name><surname>Hoefle</surname><given-names>A.</given-names></name>, <name><surname>Telles</surname><given-names>V.</given-names></name>, <name><surname>Begum</surname><given-names>K.</given-names></name></person-group>
<etal/> (<year>2001</year>) <article-title>Extensive repertoire of membrane-bound and soluble dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2 isoforms. Inter-individual variation in expression of DC-SIGN transcripts</article-title>. <source>J. Biol. Chem.</source>
<volume>276</volume>, <fpage>33196</fpage>&#x02013;<lpage>33212</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M009807200</pub-id>
<?supplied-pmid 11337487?><pub-id pub-id-type="pmid">11337487</pub-id></mixed-citation></ref><ref id="B146"><label>146</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillespie</surname><given-names>L.</given-names></name>, <name><surname>Roosendahl</surname><given-names>P.</given-names></name>, <name><surname>Ng</surname><given-names>W.C.</given-names></name>, <name><surname>Brooks</surname><given-names>A.G.</given-names></name>, <name><surname>Reading</surname><given-names>P.C.</given-names></name> and <name><surname>Londrigan</surname><given-names>S.L.</given-names></name></person-group> (<year>2016</year>) <article-title>Endocytic function is critical for influenza A virus infection via DC-SIGN and L-SIGN</article-title>. <source>Sci. Rep.</source>
<volume>6</volume>, <fpage>19428</fpage>
<pub-id pub-id-type="doi">10.1038/srep19428</pub-id>
<?supplied-pmid 26763587?><pub-id pub-id-type="pmid">26763587</pub-id></mixed-citation></ref><ref id="B147"><label>147</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Na-Ek</surname><given-names>P.</given-names></name>, <name><surname>Thewsoongnoen</surname><given-names>J.</given-names></name>, <name><surname>Thanunchai</surname><given-names>M.</given-names></name>, <name><surname>Wiboon-Ut</surname><given-names>S.</given-names></name>, <name><surname>Sa-Ard-Iam</surname><given-names>N.</given-names></name>, <name><surname>Mahanonda</surname><given-names>R.</given-names></name></person-group>
<etal/> (<year>2017</year>) <article-title>The activation of B cells enhances DC-SIGN expression and promotes of B cells to HPAI H5N1 infection</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>490</volume>, <fpage>1301</fpage>&#x02013;<lpage>1306</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2017.07.017</pub-id><pub-id pub-id-type="pmid">28688767</pub-id></mixed-citation></ref><ref id="B148"><label>148</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasta</surname><given-names>G.R.</given-names></name></person-group> (<year>2012</year>) <article-title>Galectins as pattern recognition receptors: structure, function, and evolution</article-title>. <source>Adv. Exp. Med. Biol.</source>
<volume>946</volume>, <fpage>21</fpage>&#x02013;<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4614-0106-3_2</pub-id>
<?supplied-pmid 21948360?><pub-id pub-id-type="pmid">21948360</pub-id></mixed-citation></ref><ref id="B149"><label>149</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nio-Kobayashi</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>) <article-title>Tissue- and cell-specific localization of galectins, &#x003b2;-galactose-binding animal lectins, and their potential functions in health and disease</article-title>. <source>Anat. Sci. Int.</source>
<volume>92</volume>, <fpage>25</fpage>&#x02013;<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1007/s12565-016-0366-6</pub-id>
<?supplied-pmid 27590897?><pub-id pub-id-type="pmid">27590897</pub-id></mixed-citation></ref><ref id="B150"><label>150</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasta</surname><given-names>G.R.</given-names></name></person-group> (<year>2009</year>) <article-title>Roles of galectins in infection</article-title>. <source>Nat. Rev. Microbiol.</source>
<volume>7</volume>, <fpage>424</fpage>&#x02013;<lpage>438</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro2146</pub-id>
<?supplied-pmid 19444247?><pub-id pub-id-type="pmid">19444247</pub-id></mixed-citation></ref><ref id="B151"><label>151</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M.-L.</given-names></name>, <name><surname>Chen</surname><given-names>Y.-H.</given-names></name>, <name><surname>Wang</surname><given-names>S.-W.</given-names></name>, <name><surname>Huang</surname><given-names>Y.-J.</given-names></name>, <name><surname>Leu</surname><given-names>C.-H.</given-names></name>, <name><surname>Yeh</surname><given-names>N.-C.</given-names></name></person-group>
<etal/> (<year>2011</year>) <article-title>Galectin-1 binds to influenza virus and ameliorates influenza virus pathogenesis</article-title>. <source>J. Virol.</source>
<volume>85</volume>, <fpage>10010</fpage>&#x02013;<lpage>10020</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.00301-11</pub-id>
<?supplied-pmid 21795357?><pub-id pub-id-type="pmid">21795357</pub-id></mixed-citation></ref><ref id="B152"><label>152</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.W.</given-names></name>, <name><surname>Yang</surname><given-names>T.C.</given-names></name>, <name><surname>Lai</surname><given-names>C.C.</given-names></name>, <name><surname>Huang</surname><given-names>S.H.</given-names></name>, <name><surname>Liao</surname><given-names>J.M.</given-names></name>, <name><surname>Wan</surname><given-names>L.</given-names></name></person-group>
<etal/> (<year>2014</year>) <article-title>Antiviral activity of aloe-emodin against influenza A virus via galectin-3 up-regulation</article-title>. <source>Eur. J. Pharmacol.</source>
<volume>738</volume>, <fpage>125</fpage>&#x02013;<lpage>132</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2014.05.028</pub-id>
<?supplied-pmid 24877694?><pub-id pub-id-type="pmid">24877694</pub-id></mixed-citation></ref><ref id="B153"><label>153</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name>, <name><surname>Zhou</surname><given-names>J.</given-names></name>, <name><surname>Cheng</surname><given-names>Z.</given-names></name>, <name><surname>Yang</surname><given-names>S.</given-names></name>, <name><surname>Chu</surname><given-names>H.</given-names></name>, <name><surname>Fan</surname><given-names>Y.</given-names></name></person-group>
<etal/> (<year>2015</year>) <article-title>Functional variants regulating LGALS1 (Galectin 1) expression affect human susceptibility to influenza A(H7N9)</article-title>. <source>Sci. Rep.</source>
<volume>5</volume>, <fpage>8517</fpage>
<pub-id pub-id-type="doi">10.1038/srep08517</pub-id>
<?supplied-pmid 25687228?><pub-id pub-id-type="pmid">25687228</pub-id></mixed-citation></ref><ref id="B154"><label>154</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.J.</given-names></name>, <name><surname>Wang</surname><given-names>S.F.</given-names></name>, <name><surname>Weng</surname><given-names>I.C.</given-names></name>, <name><surname>Hong</surname><given-names>M.H.</given-names></name>, <name><surname>Lo</surname><given-names>T.H.</given-names></name>, <name><surname>Jan</surname><given-names>J.T.</given-names></name></person-group>
<etal/> (<year>2018</year>) <article-title>Galectin-3 enhances avian H5N1 influenza A virus-induced pulmonary inflammation by promoting NLRP3 inflammasome activation</article-title>. <source>Am. J. Pathol.</source>
<volume>188</volume>, <fpage>1031</fpage>&#x02013;<lpage>1042</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajpath.2017.12.014</pub-id>
<?supplied-pmid 29366678?><pub-id pub-id-type="pmid">29366678</pub-id></mixed-citation></ref><ref id="B155"><label>155</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S.</given-names></name>, <name><surname>Sundararajan</surname><given-names>A.</given-names></name>, <name><surname>Suryawanshi</surname><given-names>A.</given-names></name>, <name><surname>Kumar</surname><given-names>N.</given-names></name>, <name><surname>Veiga-Parga</surname><given-names>T.</given-names></name>, <name><surname>Kuchroo</surname><given-names>V.K.</given-names></name></person-group>
<etal/> (<year>2011</year>) <article-title>T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>108</volume>, <fpage>19001</fpage>&#x02013;<lpage>19006</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1107087108</pub-id><pub-id pub-id-type="pmid">22052881</pub-id></mixed-citation></ref><ref id="B156"><label>156</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname><given-names>S.</given-names></name>, <name><surname>Ikeda</surname><given-names>M.</given-names></name>, <name><surname>Shimizu</surname><given-names>H.</given-names></name>, <name><surname>Mouri</surname><given-names>K.</given-names></name>, <name><surname>Obase</surname><given-names>Y.</given-names></name>, <name><surname>Kobashi</surname><given-names>Y.</given-names></name></person-group>
<etal/> (<year>2014</year>) <article-title>Increased levels of plasma galectin-9 in patients with influenza virus infection</article-title>. <source>Tohoku J. Exp. Med.</source>
<volume>232</volume>, <fpage>263</fpage>&#x02013;<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1620/tjem.232.263</pub-id>
<?supplied-pmid 24695077?><pub-id pub-id-type="pmid">24695077</pub-id></mixed-citation></ref><ref id="B157"><label>157</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chernyy</surname><given-names>E.S.</given-names></name>, <name><surname>Rapoport</surname><given-names>E.M.</given-names></name>, <name><surname>Andre</surname><given-names>S.</given-names></name>, <name><surname>Kalther</surname><given-names>H.</given-names></name>, <name><surname>Gabius</surname><given-names>H.J.</given-names></name> and <name><surname>Bovin</surname><given-names>N.V.</given-names></name></person-group> (<year>2011</year>) <article-title>Galectins promote the interaction of influenza virus with its target cells</article-title>. <source>Biochemistry</source>
<volume>76</volume>, <fpage>958</fpage>&#x02013;<lpage>967</lpage>
<pub-id pub-id-type="doi">10.1134/S0006297911080128</pub-id><pub-id pub-id-type="pmid">22022970</pub-id></mixed-citation></ref><ref id="B158"><label>158</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nita-Lazar</surname><given-names>M.</given-names></name>, <name><surname>Banerjee</surname><given-names>A.</given-names></name>, <name><surname>Feng</surname><given-names>C.</given-names></name>, <name><surname>Amin</surname><given-names>M.N.</given-names></name>, <name><surname>Frieman</surname><given-names>M.B.</given-names></name>, <name><surname>Chen</surname><given-names>W.H.</given-names></name></person-group>
<etal/> (<year>2015</year>) <article-title>Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding</article-title>. <source>Mol. Immunol.</source>
<volume>65</volume>, <fpage>1</fpage>&#x02013;<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1016/j.molimm.2014.12.010</pub-id>
<?supplied-pmid 25597246?><pub-id pub-id-type="pmid">25597246</pub-id></mixed-citation></ref><ref id="B159"><label>159</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsushita</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>) <article-title>Ficolins: complement-activating lectins involved in innate immunity</article-title>. <source>J. Innate Immun.</source>
<volume>2</volume>, <fpage>24</fpage>&#x02013;<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1159/000228160</pub-id>
<?supplied-pmid 20375620?><pub-id pub-id-type="pmid">20375620</pub-id></mixed-citation></ref><ref id="B160"><label>160</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichijo</surname><given-names>H.</given-names></name>, <name><surname>Ronnstrand</surname><given-names>L.</given-names></name>, <name><surname>Miyagawa</surname><given-names>K.</given-names></name>, <name><surname>Ohashi</surname><given-names>H.</given-names></name>, <name><surname>Heldin</surname><given-names>C.H.</given-names></name> and <name><surname>Miyazono</surname><given-names>K.</given-names></name></person-group> (<year>1991</year>) <article-title>Purification of transforming growth factor-beta 1 binding proteins from porcine uterus membranes</article-title>. <source>J. Biol. Chem.</source>
<volume>266</volume>, <fpage>22459</fpage>&#x02013;<lpage>22464</lpage>
<?supplied-pmid 1657997?><pub-id pub-id-type="pmid">1657997</pub-id></mixed-citation></ref><ref id="B161"><label>161</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endo</surname><given-names>Y.</given-names></name>, <name><surname>Sato</surname><given-names>Y.</given-names></name>, <name><surname>Matsushita</surname><given-names>M.</given-names></name> and <name><surname>Fujita</surname><given-names>T.</given-names></name></person-group> (<year>1996</year>) <article-title>Cloning and characterization of the human lectin P35 gene and its related gene</article-title>. <source>Genomics</source>
<volume>36</volume>, <fpage>515</fpage>&#x02013;<lpage>521</lpage>
<pub-id pub-id-type="doi">10.1006/geno.1996.0497</pub-id>
<?supplied-pmid 8884275?><pub-id pub-id-type="pmid">8884275</pub-id></mixed-citation></ref><ref id="B162"><label>162</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J.</given-names></name>, <name><surname>Le</surname><given-names>Y.</given-names></name>, <name><surname>Kon</surname><given-names>O.L.</given-names></name>, <name><surname>Chan</surname><given-names>J.</given-names></name> and <name><surname>Lee</surname><given-names>S.H.</given-names></name></person-group> (<year>1996</year>) <article-title>Biosynthesis of human ficolin, an Escherichia coli-binding protein, by monocytes: comparison with the synthesis of two macrophage-specific proteins, C1q and the mannose receptor</article-title>. <source>Immunology</source>
<volume>89</volume>, <fpage>289</fpage>&#x02013;<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2567.1996.d01-732.x</pub-id><pub-id pub-id-type="pmid">8943728</pub-id></mixed-citation></ref><ref id="B163"><label>163</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugimoto</surname><given-names>R.</given-names></name>, <name><surname>Yae</surname><given-names>Y.</given-names></name>, <name><surname>Akaiwa</surname><given-names>M.</given-names></name>, <name><surname>Kitajima</surname><given-names>S.</given-names></name>, <name><surname>Shibata</surname><given-names>Y.</given-names></name>, <name><surname>Sato</surname><given-names>H.</given-names></name></person-group>
<etal/> (<year>1998</year>) <article-title>Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family</article-title>. <source>J. Biol. Chem.</source>
<volume>273</volume>, <fpage>20721</fpage>&#x02013;<lpage>20727</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.273.33.20721</pub-id>
<?supplied-pmid 9694814?><pub-id pub-id-type="pmid">9694814</pub-id></mixed-citation></ref><ref id="B164"><label>164</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J.</given-names></name>, <name><surname>Le</surname><given-names>Y.</given-names></name>, <name><surname>Kon</surname><given-names>O.L.</given-names></name>, <name><surname>Chan</surname><given-names>J.</given-names></name> and <name><surname>Lee</surname><given-names>S.H.</given-names></name></person-group> (<year>1996</year>) <article-title>Biosynthesis of human ficolin, an Escherichia coli-binding protein, by monocytes: Comparison with the synthesis of two macrophage-specific proteins, C1q and the mannose receptor</article-title>. <source>Immunology</source>
<volume>89</volume>, <fpage>289</fpage>&#x02013;<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2567.1996.d01-732.x</pub-id><pub-id pub-id-type="pmid">8943728</pub-id></mixed-citation></ref><ref id="B165"><label>165</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsushita</surname><given-names>M.</given-names></name>, <name><surname>Endo</surname><given-names>Y.</given-names></name>, <name><surname>Taira</surname><given-names>S.</given-names></name>, <name><surname>Sato</surname><given-names>Y.</given-names></name>, <name><surname>Fujita</surname><given-names>T.</given-names></name>, <name><surname>Ichikawa</surname><given-names>N.</given-names></name></person-group>
<etal/> (<year>1996</year>) <article-title>A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin</article-title>. <source>J. Biol. Chem.</source>
<volume>271</volume>, <fpage>2448</fpage>&#x02013;<lpage>2454</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.271.5.2448</pub-id>
<?supplied-pmid 8576206?><pub-id pub-id-type="pmid">8576206</pub-id></mixed-citation></ref><ref id="B166"><label>166</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akaiwa</surname><given-names>M.</given-names></name>, <name><surname>Yae</surname><given-names>Y.</given-names></name>, <name><surname>Sugimoto</surname><given-names>R.</given-names></name>, <name><surname>Suzuki</surname><given-names>S.O.</given-names></name>, <name><surname>Iwaki</surname><given-names>T.</given-names></name>, <name><surname>Izuhara</surname><given-names>K.</given-names></name></person-group>
<etal/> (<year>1999</year>) <article-title>Hakata antigen, a new member of the ficolin/opsonin p35 family, is a novel human lectin secreted into bronchus/alveolus and bile</article-title>. <source>J. Histochem. Cytochem.</source>
<volume>47</volume>, <fpage>777</fpage>&#x02013;<lpage>786</lpage>
<pub-id pub-id-type="doi">10.1177/002215549904700607</pub-id>
<?supplied-pmid 10330454?><pub-id pub-id-type="pmid">10330454</pub-id></mixed-citation></ref><ref id="B167"><label>167</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name>, <name><surname>Endo</surname><given-names>Y.</given-names></name>, <name><surname>Iwaki</surname><given-names>D.</given-names></name>, <name><surname>Nakata</surname><given-names>M.</given-names></name>, <name><surname>Matsushita</surname><given-names>M.</given-names></name>, <name><surname>Wada</surname><given-names>I.</given-names></name></person-group>
<etal/> (<year>2005</year>) <article-title>Human M-ficolin is a secretory protein that activates the lectin complement pathway</article-title>. <source>J. Immunol.</source>
<volume>175</volume>, <fpage>3150</fpage>&#x02013;<lpage>3156</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.175.5.3150</pub-id>
<?supplied-pmid 16116205?><pub-id pub-id-type="pmid">16116205</pub-id></mixed-citation></ref><ref id="B168"><label>168</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilpatrick</surname><given-names>D.C.</given-names></name>, <name><surname>Fujita</surname><given-names>T.</given-names></name> and <name><surname>Matsushita</surname><given-names>M.</given-names></name></person-group> (<year>1999</year>) <article-title>P35, an opsonic lectin of the ficolin family, in human blood from neonates, normal adults, and recurrent miscarriage patients</article-title>. <source>Immunol. Lett.</source>
<volume>67</volume>, <fpage>109</fpage>&#x02013;<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-2478(98)00147-3</pub-id>
<?supplied-pmid 10232391?><pub-id pub-id-type="pmid">10232391</pub-id></mixed-citation></ref><ref id="B169"><label>169</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munthe-Fog</surname><given-names>L.</given-names></name>, <name><surname>Hummelshoj</surname><given-names>T.</given-names></name>, <name><surname>Hansen</surname><given-names>B.E.</given-names></name>, <name><surname>Koch</surname><given-names>C.</given-names></name>, <name><surname>Madsen</surname><given-names>H.O.</given-names></name>, <name><surname>Skjodt</surname><given-names>K.</given-names></name></person-group>
<etal/> (<year>2007</year>) <article-title>The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels</article-title>. <source>Scand. J. Immunol.</source>
<volume>65</volume>, <fpage>383</fpage>&#x02013;<lpage>392</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-3083.2007.01915.x</pub-id>
<?supplied-pmid 17386030?><pub-id pub-id-type="pmid">17386030</pub-id></mixed-citation></ref><ref id="B170"><label>170</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittenborn</surname><given-names>T.</given-names></name>, <name><surname>Thiel</surname><given-names>S.</given-names></name>, <name><surname>Jensen</surname><given-names>L.</given-names></name>, <name><surname>Nielsen</surname><given-names>H.J.</given-names></name> and <name><surname>Jensenius</surname><given-names>J.C.</given-names></name></person-group> (<year>2010</year>) <article-title>Characteristics and biologicalvariations of M-ficolin, a pattern recognition molecule, in plasma</article-title>. <source>J. Innate Immunol.</source>
<volume>2</volume>, <fpage>167</fpage>&#x02013;<lpage>180</lpage>
<pub-id pub-id-type="doi">10.1159/000218324</pub-id>
<?supplied-pmid 20375634?><pub-id pub-id-type="pmid">20375634</pub-id></mixed-citation></ref><ref id="B171"><label>171</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>A.</given-names></name>, <name><surname>White</surname><given-names>M.</given-names></name>, <name><surname>Vathipadiekal</surname><given-names>V.</given-names></name>, <name><surname>Tripathi</surname><given-names>S.</given-names></name>, <name><surname>Mbianda</surname><given-names>J.</given-names></name>, <name><surname>Ieong</surname><given-names>M.</given-names></name></person-group>
<etal/> (<year>2012</year>) <article-title>Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses</article-title>. <source>J. Immunol.</source>
<volume>189</volume>, <fpage>2478</fpage>&#x02013;<lpage>2487</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1103786</pub-id>
<?supplied-pmid 22851708?><pub-id pub-id-type="pmid">22851708</pub-id></mixed-citation></ref><ref id="B172"><label>172</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>M.R.</given-names></name>, <name><surname>Tripathi</surname><given-names>S.</given-names></name>, <name><surname>Kingma</surname><given-names>P.</given-names></name>, <name><surname>Takahashi</surname><given-names>K.</given-names></name>, <name><surname>Jensenius</surname><given-names>J.</given-names></name>, <name><surname>Thiel</surname><given-names>S.</given-names></name></person-group>
<etal/> (<year>2017</year>) <article-title>Collectins, H-ficolin and LL-37 reduce influence viral replication in human monocytes and modulate virus-induced cytokine production</article-title>. <source>Innate Immunol.</source>
<volume>23</volume>, <fpage>77</fpage>&#x02013;<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1177/1753425916678470</pub-id>
<?supplied-pmid 27856789?><pub-id pub-id-type="pmid">27856789</pub-id></mixed-citation></ref><ref id="B173"><label>173</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>Q</given-names></name>, <name><surname>Chen</surname><given-names>H.</given-names></name>, <name><surname>Wang</surname><given-names>F.</given-names></name>, <name><surname>Jeza</surname><given-names>V.T.</given-names></name>, <name><surname>Hou</surname><given-names>W.</given-names></name>, <name><surname>Zhao</surname><given-names>Y.</given-names></name></person-group>
<etal/> (<year>2012</year>) <article-title>L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza A virus infection both <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source>J. Innate Immunol.</source>
<volume>4</volume>, <fpage>312</fpage>&#x02013;<lpage>324</lpage>
<pub-id pub-id-type="doi">10.1159/000335670</pub-id>
<?supplied-pmid 22399010?><pub-id pub-id-type="pmid">22399010</pub-id></mixed-citation></ref><ref id="B174"><label>174</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crouch</surname><given-names>E.</given-names></name>, <name><surname>Nikolaidis</surname><given-names>N.</given-names></name>, <name><surname>McCormack</surname><given-names>F.X.</given-names></name>, <name><surname>McDonald</surname><given-names>B.</given-names></name>, <name><surname>Allen</surname><given-names>K.</given-names></name>, <name><surname>Rynkiewicz</surname><given-names>M.J.</given-names></name></person-group>
<etal/> (<year>2011</year>) <article-title>Mutagenesis of surfactant protein D informed by evolution and x-ray rystallography enhances defenses against influenza A virus <italic>in vivo</italic></article-title>. <source>J. Biol. Chem.</source>
<volume>286</volume>, <fpage>40681</fpage>&#x02013;<lpage>40692</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111.300673</pub-id>
<?supplied-pmid 21965658?><pub-id pub-id-type="pmid">21965658</pub-id></mixed-citation></ref><ref id="B175"><label>175</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Ahdal</surname><given-names>M.N.</given-names></name>, <name><surname>Murugaiah</surname><given-names>V.</given-names></name>, <name><surname>Varghese</surname><given-names>P.M.</given-names></name>, <name><surname>Abozaid</surname><given-names>S.M.</given-names></name>, <name><surname>Saba</surname><given-names>I.</given-names></name>, <name><surname>Al-Qahtani</surname><given-names>A.A.</given-names></name></person-group>
<etal/> (<year>2018</year>) <article-title>Entry inhibition and modulation of pro-inflammatory immune response against influenza A virus by recombinant truncated surfactant protein D</article-title>. <source>Front. Immunol.</source>
<volume>9</volume>, <fpage>1586</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2018.01586</pub-id>
<?supplied-pmid 30105014?><pub-id pub-id-type="pmid">30105014</pub-id></mixed-citation></ref><ref id="B176"><label>176</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillaire</surname><given-names>M.L.</given-names></name>, <name><surname>van Eijk</surname><given-names>M.</given-names></name>, <name><surname>Vogelzang-van Trierum</surname><given-names>S.E.</given-names></name>, <name><surname>Fouchier</surname><given-names>R.A.</given-names></name>, <name><surname>Osterhaus</surname><given-names>A.D.</given-names></name>, <name><surname>Haagsman</surname><given-names>H.P.</given-names></name></person-group>
<etal/> (<year>2014</year>) <article-title>Recombinant porcine surfactant protein D inhibits influenzaA virus replication <italic>ex vivo</italic></article-title>. <source>Virus Res.</source>
<volume>181</volume>, <fpage>22</fpage>&#x02013;<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1016/j.virusres.2013.12.032</pub-id>
<?supplied-pmid 24389095?><pub-id pub-id-type="pmid">24389095</pub-id></mixed-citation></ref><ref id="B177"><label>177</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Eijk</surname><given-names>M.</given-names></name>, <name><surname>Rynkiewicz</surname><given-names>M.J.</given-names></name>, <name><surname>Khatri</surname><given-names>K.</given-names></name>, <name><surname>Leymarie</surname><given-names>N.</given-names></name>, <name><surname>Zaia</surname><given-names>J.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name></person-group>
<etal/> (<year>2018</year>) <article-title>Lectin-mediated binding and sialoglycans of porcine surfactant protein D synergistically neutralize influenza A virus</article-title>. <source>J. Biol. Chem.</source>
<volume>293</volume>, <fpage>10646</fpage>&#x02013;<lpage>10662</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.RA117.001430</pub-id>
<?supplied-pmid 29769321?><pub-id pub-id-type="pmid">29769321</pub-id></mixed-citation></ref><ref id="B178"><label>178</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>W.C.</given-names></name>, <name><surname>Hartshorn</surname><given-names>K.L.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name>, <name><surname>Moyo</surname><given-names>P.</given-names></name>, <name><surname>Michelow</surname><given-names>I.C.</given-names></name>, <name><surname>Koziel</surname><given-names>H.</given-names></name></person-group>
<etal/> (<year>2011</year>) <article-title>Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin</article-title>. <source>Biochem. Pharmacol.</source>
<volume>81</volume>, <fpage>388</fpage>&#x02013;<lpage>395</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2010.10.012</pub-id>
<?supplied-pmid 21035429?><pub-id pub-id-type="pmid">21035429</pub-id></mixed-citation></ref><ref id="B179"><label>179</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K.</given-names></name>, <name><surname>Moyo</surname><given-names>P.</given-names></name>, <name><surname>Chigweshe</surname><given-names>L.</given-names></name>, <name><surname>Chang</surname><given-names>W.C.</given-names></name>, <name><surname>White</surname><given-names>M.R.</given-names></name> and <name><surname>Hartshorn</surname><given-names>K.L.</given-names></name></person-group> (<year>2013</year>) <article-title>Efficacy of recombinant chimeric lectins, consisting of mannose binding lectin and L-ficolin, against influenzaA viral infection in mouse model study</article-title>. <source>Virus Res.</source>
<volume>178</volume>, <fpage>495</fpage>&#x02013;<lpage>501</lpage>
<pub-id pub-id-type="doi">10.1016/j.virusres.2013.10.001</pub-id>
<?supplied-pmid 24140629?><pub-id pub-id-type="pmid">24140629</pub-id></mixed-citation></ref><ref id="B180"><label>180</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rota</surname><given-names>P.A.</given-names></name>, <name><surname>Wallis</surname><given-names>T.R.</given-names></name>, <name><surname>Harmon</surname><given-names>M.W.</given-names></name>, <name><surname>Rota</surname><given-names>J.S.</given-names></name>, <name><surname>Kendal</surname><given-names>A.P.</given-names></name> and <name><surname>Nerome</surname><given-names>K.</given-names></name></person-group> (<year>1990</year>) <article-title>Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983</article-title>. <source>Virology</source>
<volume>175</volume>, <fpage>59</fpage>&#x02013;<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1016/0042-6822(90)90186-U</pub-id><pub-id pub-id-type="pmid">2309452</pub-id></mixed-citation></ref></ref-list></back></article>